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Abstract
The state of the art for DNA sequencing has reached the point where it is economically feasible to sequence
entire genomes in a matter of a few years. The demand for this data both from public research institutions
and private enterprises is tremendous, as evidenced by the entry of several companies in 1998 to challenge
the NIH funded Human Genome Project to a race to sequence the Human Genome.
This particular study involves the use of manufacturing strategy and tactics to help a research-based
institution such as the Whitehead Institute achieve their production sequencing goals. The findings of this
study illustrate the remarkable speed at which new technologies are implemented in the field and
subsequent organization and execution challenges that face these high technology centers.
The manufacturing tools applied include constraint management, variation reduction, organizational
alignment, quality assurance rationalization and inventory management. In the area of constraint
management, a scale-up tool was developed to gain insights of potential problems and opportunities
involved in scaling up throughput by a factor of three. Variation reduction was accomplished by the use of
better documentation, work standardization, key performance measurement and statistical analysis. The
impact of organizational structure was analyzed and cross-training was found to be particularly helpful in
advancing knowledge transfer, lowering variability and debottlenecking. Quality assurance was updated
for various steps of the process, resulting in potential cost savings. Finally, a model was developed to
calculate optimum inventory levels for the core sequencing operation, which will enable more rapid ramp
up of new process developments.
The thesis ends with a discussion about the choice of using incremental or radical improvement and
concludes that if scale-up data are available, that radical improvement is better for high variability, unstable
processes, while incremental improvement is better for low variability, robust processes.
Thesis Advisors:
Professor Charles L. Cooney, Department of Chemical Engineering
Professor Stephen C. Graves, Sloan School of Management
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I. Introduction
The Human Genome Project is like no other project ever before initiated by the scientific
community due to its scale, timeframe and degree of international collaboration. The
Human Genome Project was officially launched in the United States on October 1, 1990,
funded by the National Institutes of Health (NIH), the Department of Energy (DOE), the
Wellcome Trust and other governments and foundations throughout the world. The
project ultimately involves sequencing the human genome as well as several model
organisms and developing new technologies to understand gene functionality.
Eager to take advantage of the basic sequencing data provided by the project, most
biotechnology, pharmaceutical and research institutions are anxious to speed up the
sequencing process as much as possible. Indeed, the impact of private enterprises to
more rapidly discover genetic data has influenced the Human Genome Project timeline
and approach. The goal at the beginning of 1998 was to have the genome sequenced by
2005. By the end of 1998, partially in response to challenges by the private sector,' the
project's timetable was accelerated to complete by 2003.2
Completion of the project will require running tens of billions base pair analyses.
Because of the repetitive, large volume nature of the work, some research organizations
call this phase "production sequencing." In order to meet these goals, the researchers
involved need to adopt process technologies, innovation and discipline not usually
employed in lab settings. By applying some of the manufacturing tools and methods
devised in the last two centuries, the goal of sequencing the Human Genome may be
achievable within this timeframe.
"Shotgun Sequencing of the Human Genome," Science, Vol. 280 (5 Jun 1998), pp. 1540-1542.
2 "New Goals for the U.S. Human Genome Project: 1998-2003," Science, Vol. 282 (23 Oct 1998), pp. 682-
689
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A. Background
The "human genome" is defined as "the full set of genetic instructions that make up a
human being." 3 Deoxyribonucleic acid (DNA) is codified using a four-letter system
(base pairs A, C, T or G), with three-letter "words" called codons (i.e. AAA, TGA, etc.).
Each codon represents either an amino acid or a signal that the protein replication is
finished. Since proteins are composed of amino acids, every protein found in nature can
be made by following a DNA template. The DNA template for the entire protein is
called a gene. It is estimated that there are 80,000 to 120,000 genes in the human
genome.
One can analogize the entire three-billion base pair sequence for a particular person to the
"source code" of a computer program. Having the "source code" does not convey the
functionality of the program unless one understands what the "subroutines" encoded
actually do, what makes them execute and what specific outputs they provide. Similarly,
knowing the DNA sequence of a person is akin to knowing the entire source code, and
the genes are the subroutines of the program. There are two remarkable principles at
work here: First, although humans have small differences (1 in 10,000) in their genomes
("source code"), all have the same number of genes, allowing a basis for comparison that
can be used to better understand the function of each "subroutine". Second, genes are
conserved to some degree in nature. That is, although evolution has forced divergent
paths for different organisms, many of the key genes are similar to some degree, allowing
study of analogous functions.
Further, the biological principles outlined above can be coupled with the use of
technology in order to accelerate the understanding of gene function. Using recombinant
technology, it is possible to insert genes or DNA from one organism to another. This
technology enables scientists to induce an organism to produce ("express") a protein of
interest even if it comes from a foreign gene. Similarly, DNA from a foreign source can
3 " A Gene Map of the Human Genome: International Group Maps a Fifth of all Genes of the Human
Genome", MIT/Whitehead Institute Publication, 1997
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be inserted into an organism that can be induced to replicate, thus providing copies of the
original DNA. The Human Genome Project is motivated on the belief that having a
baseline for comparison between human and model organisms will accelerate and enable
gene discovery and understanding of gene functionality.
The NIH organized the Human Genome Project by creating a division called the National
Human Genome Research Institute, which coordinates between and provides funding for
sequencing centers to decipher certain parts of the genome. The major sequencing
centers are the University of Texas Southwestern Medical Center, Baylor College of
Medicine, Whitehead Institute/MIT, Stanford University, University of Washington,
University of Oklahoma and Washington University. The goals for the period 1993-1998
and the status as of October, 1998 are shown in Table 1:4
Table 1: U.S. Human Genome Project Status as of October, 1998.
Area Goal (1993-1998) Status (Oct. 1998)
Genetic Map 2-5 centiMorgan resolution 1 cM map Sept. 1994
Physical Map 30,000 STS's 52,000 STS's mapped
DNA Sequenced 80 million base pairs 291 million base pairs
Sequencing Technology Radical and incremental $0.50 per base pair
improvements Capillary electrophoresis
Microfabrication feasible
Gene identification Develop technology 30,000 EST's mapped
Model organisms E. coli: complete sequence Completed Sept. 1997
Yeast: complete sequence Completed Apr. 1996
C. elegans: most sequence Completed Dec. 1998
Drosophila: begin sequence 9% done
Mouse: 10,000 STS's 12,000 STS's mapped
The genetic map of the human genome was completed in 1994. The genetic map
compares phenotypes, which are the physical attributes that genes convey, for example
blue versus brown eyes. This effort produces a genetic (also called linkage) map, used to
determine the order and relative distances between genes.
4 "New Goals for the U.S. Human Genome Project: 1998-2003", Science, Vol. 282 (23 Oct 1998), pp. 682-
689.
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The mapping of the human genome was done in order to obtain enough information to
start the process of sequencing. One main way of physically mapping utilizes sequence-
tagged sites (STS's), which are known, short-length sequences (for example AAGCTG)
that can be used to roughly find out where a particular piece of DNA belongs.
As shown in Table 1, the project has done very well so far in meeting its sequencing
goals, although there was a period where the project was struggling. In fact, as recently
as May 1998, there were reports that none of the major sequencing centers had met their
two-year sequencing goals.5 The main reasons for the problems in meeting the goals
were the technological and organizational challenges required of step increases in output.
The state of the art in 1993 was such that large scale-up of existing DNA sequencing
technologies would be prohibitively expensive. Thus, one of the major goals of the initial
part of the project was to help seed advancement of new technologies required to execute
the process cost-effectively. There have been many process improvements in the seven
years since the Human Genome Project started. Some of the improvements include:
higher efficiency recombinant organisms; robotic automation of the preparation
procedures; DNA sequence analyzers with higher resolutions and longer read lengths;
more robust and standardized data assembly software (informatics); and more refined
techniques on preventing and closing gaps.
Indeed, one can characterize the state of DNA sequencing technology to be at the growth
part of the S-curve,6 meaning that there is less effort needed for the same amount of
process improvement. It is well known that when technologies reach the growth part of
the S-curve, efficiencies and economies of scale become more important than new
developments 7. The evolution of technology is a challenge that all sequencing centers
should take seriously, in that attention should be shifted to building economies of scale
and productivity.
5 "DNA Sequencers' Trial by Fire", Science, Vol. 280, (8 May 1998), pp. 814-817.
6 Foster, R., Innovation, The Attacker's Advantage, (NY: Summit Books, Simon and Schuster, 1986),
pp.88-111.
7 Rebecca Henderson, Notes from Technology Strategy course at MIT (Fall, 1998).
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However, as discussed by Foster (op. cited), S-curves usually come in pairs, with the
advent of new dominant designs eventually replacing old paradigms. Organizations that
over-focus on one S-curve will be at a disadvantage relative to the competition, who may
already be one the next generation S-curve. Therefore, while organizations should focus
on being productive, they must also be flexible enough to move to the new S-curve as the
technology changes.
The NIH recognized that in order to understand gene functionality, they must first find
out which proteins are expressed in organisms, as they give great clues as to what parts of
the DNA sequence are actually used. These proteins lead to expressed-sequenced tags
(EST's), which are sequences that are known to originate from a particular gene because
they correspond to proteins that are actually being produced in living organisms.
Finally, as mentioned earlier, the elucidation of DNA sequences of model organisms
serves as a platform by which to understand human gene function, due to the similarities
in gene function found in nature.
There are additional goals for the Human Genome project for the next five years,
including:
e Increase aggregate (all centers) sequencing capability from 90 to 500 Mb/year.
" Decrease cost of finished sequence to $0.25/base.
" Map 100,000 single-nucleotide polymorphisms (SNP's or "snips"), which are
differences in sequence from one human to another of one nucleotide base.
" Develop more efficient ways of identifying genes.
" Develop technologies to elucidate gene function.
Curiously enough, according to the NIH model, the same organizations that do genetic
research such as studying gene functionality will also do production sequencing , which
requires entire new competencies focusing on productivity. Therefore, these
organizations must build these competencies as well as keep their old ones, becoming
more vertically integrated. Such organizations will face many of the same challenges that
9
pharmaceutical companies do: having to balance two competencies, in their case
research and marketing.
This thesis focuses on the goal of high-efficiency (production) DNA sequencing, which
was the focus of the internship at the Whitehead Institute Center for Genome Research.
B. State of the Art During the Internship
The NIH, in collaboration with the main sequencing centers, establishes the guidelines
for the process of DNA sequencing. The highly accurate approach involved five main
steps, shown below:
DNA Library DNA DNA Data Finishing DNAMapping and preparation Sequencing Assembly
Sourc Cnnit~ Data
This process analyzes small pieces of the genome at a time. The source DNA source (also
called a BAC clone) is a small, very roughly mapped portion of the entire genome, about
100,000 "base pairs" long. Library Mapping accurately maps the source to a region of
the genome by comparing it against known markers. In Library Construction, the DNA
source is replicated, purified, sheared into small pieces and presented to the DNA
preparation step packaged as a collection of recombinant organisms (a "library" of
organisms that, in aggregate, have all of the original DNA source). In the DNA
preparation step, the DNA in recombinant form is replicated, purified and molecular
"dye" is added to it using PCR technology developed in the 1980's. Once the DNA
pieces are prepped, they are sent to sequencing machines that use gel electrophoresis and
fluorescence detection to analyze their sequences. The data from the sequencing
machines are used to re-assemble the sequence of the entire original piece of DNA. After
data assembly, if any gaps remain, that is, if any parts of the original DNA source that for
some reason did not sequence, the process is "finished" by applying a variety of special
techniques that depend on the nature of the problem. One can look at the finishing step
as rework or as a consequence of the limitations of existing technology to produce error-
free output. Usually, it is a combination of both, although it is mostly the latter at
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Whitehead. The final output is the DNA data or "sequence" of the original DNA source
(100,000 base pairs worth). This whole process is repeated tens of thousands of time in
order to sequence the entire human genome, which has 3 billion base pairs.
C. Challenge to the State of the Art
On May 9, 1998, J. Craig Venter, founder of The Institute For Genome Research
(Bethesda, MD) and Michael Hunkapiller, president of the Perkin-Elmer's (Norwalk, CT)
Applied Biosystems Division announced that they were forming a new company to
sequence of the entire human genome in three years at a cost of about $300 million. At
the time, the principals of the new venture communicated that the company would try to
patent around 100-300 new genes, create a whole-genome database to market to
academic researchers and companies on a subscription basis and have a proprietary set of
100,000 single-nucleotide polymorphisms (SNP's), which reveal simple variations in
DNA between individuals. This announcement came as a shock to the biomedical
research community, which expected to take an additional seven years and expenditures
of $1.5 billion to finish the Human Genome Project.
On September 23, 1998, Perkin-Elmer announced the creation of a new business division
called Celera, which will trade on the open market as a targeted stock: "Its mission is to
become the definitive source for genomic and related biomedical information. Celera's
plans include: 1) sequencing (draft) of the complete human genome during the next three
years; 2) discovering new genes and regulatory sequences that could comprise new drug
targets; and 3) elucidating human genetic variation and its association with disease
susceptibility and treatment response. Celera plans to create commercial value through
the license or sale of databases, knowledge-bases, proprietary drug targets and genetic
markers, and related partnership services."8 Trading Celera as a targeted stock, rather
than an independent company, presumes that Perkin-Elmer wants to keep close
managerial control of and add synergy to the new enterprise. Additionally, by keeping
8 PERKIN-ELMER ANNOUNCES PROPOSED DISTRIBUTION OF CELERA GENOMICS
TARGETED STOCK", Perkin-Elmer Corporate Public Announcement, NORWALK, CT, September 23,
1998.
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close ties with Celera, Perkin-Elmer will increase their absorptive and commercialization
capacity into instrument systems and reagents, their core businesses. Perkin-Elmer plans
to internally subsidize the new stock issue, signaling high confidence in the venture.
Celera proposes to eliminate the labor-intensive steps of library mapping and eliminate
finishing altogether:
DNA Library DNA DNA Data DNA
Su Mapping and preparation Sequencing Assembly OData
This process sequences the entire genome in one shot. The DNA source is the 3 billion
base pairs that make up the entire human genome. The middle of the process is similar to
the NIH approach, but with much less generation of data per DNA source. In Library
Construction, the DNA is replicated, purified, sheared into small pieces and presented to
the DNA preparation step packaged as collection of recombinant. In the DNA
preparation step, the DNA in recombinant form is replicated, purified and molecular
"dye" added to it using PCR technology. Once the DNA pieces are prepped, they are
sent to sequencing machines to analyze their sequences. The data from the sequencing
machines are used to re-assemble the sequence of the entire original piece of DNA. The
"gaps" are not finished and the final output is the entire DNA genome data.
In addition to eliminating the portions of the NIH process, Celera plans on using Perkin-
Elmer's new capillary electrophoresis machines for the DNA sequencing. However,
versions of these capillary machines (made from Perkin-Elmer's competitors) are already
available to the NIH centers.9
The impact of the Celera challenge was to change the NIH approach to obtain a rough
version of the genome, with continuing refinement in resolution to come at a later date. It
9 "Sequencing the Genome, Fast", Science, Vol. 283, (19 March 1999), pp. 1867-1868.
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is in this challenging environment that the Whitehead Institute entered their third year of
DNA sequencing operations.
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1I. Statement of the Problem
The problem facing the Whitehead Institute's Center for Genome Research was to scale
up their operations while keeping high quality output and meeting cost targets outlined by
their research grants. Additionally, they had various development projects in their
pipeline aimed at minimizing the labor costs, lowering reagent costs and increasing
efficiency. Their goal for June 1998-June 1999 was to sequence 16 million base pairs at
a cost of $0.50 per finished base pair. The purpose of the internship was to provide
manufacturing perspective and knowledge to their research-oriented culture by helping
them formulate and execute various manufacturing strategies. This is relevant as they
enter the production sequencing phase of the project.
This thesis will trace various manufacturing strategies implemented at the Whitehead
Institute, where due to the recent scale-up of the Human Genome Project, parts of the
Center for Genome Sequencing was transitioning from a research to a factory culture at
an accelerating rate.
In particular, this thesis will examine two areas in detail:
1. Application of manufacturing tools - what worked, what did not and why. The
choice of manufacturing tools was based on discussions and agreements with local
management.
a. Constraint management:
0 Core Sequencing Manufacturing Scalability Model
b. Variation Reduction:
e Core Sequencing
e Library Construction
c. Organizational structure:
e Analysis and recommendations for Core Sequencing
d. Quality Assurance:
0 QA in Core Sequencing
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0 QA in Library Construction
e. Inventory Management:
* Effect on inventory on throughput and development speed.
The approach to address the manufacturing concerns was to have an initial kick-off
meeting with the Center's top management in order to discuss the burning issues. At the
conclusion of the first meetings, we decided that objectives for the project were first to
build a model of the core sequencing operations, and then to use the model to bring a
manufacturing perspective by executing it in a variety of projects to increase output and
decrease cost.
The approach was to apply manufacturing tools in operational areas deemed to be ready
for production sequencing. Although the overall system was constrained in the finishing
operations, the main emphasis was to elevate the constraints of the core sequencing
operations, followed by the library construction area. The main point of the thesis is to
evaluate the impact of various manufacturing tools on the output and efficiency of the
operation. Since there were a variety of improvement efforts going in parallel, it is
difficult to separate the effects that these tools have. Therefore, the evaluations of how
well the tools worked will be more qualitative in nature.
2. Process development decision support hypothesis
How does an operations manager choose between an incremental or radical improvement
effort? In addition to throughput and cost considerations, operations leaders must
sometimes choose between committing resources for radical improvement efforts or
incrementally improving the process. Although constraint theory helps pinpoint where to
apply resources, it does not address the next decision: to try radical or incremental
improvement.
In a process where many bottlenecks and scale-up considerations constrain the process,
the operational manager must assign limited development resources so that they deliver
15
throughput improvements at the appropriate time. The choice of addressing
improvements as incremental or radical is a matter of technical and organizational
judgement. Nevertheless, a framework with which to think about this problem could help
to make better decisions. The hypothesis assumes that scale-up data are available for a
new process, which would provide a radical improvement in terms of productivity. If the
process has high variation, making it more difficult to make incremental improvements,
the decision should be to try the radical improvement. Conversely, if the process has low
variability, the decision should be to do incremental improvement, as it is less disruptive
and more economical.
An attempt will be made to quantify the variability of various processes, classify the
improvement efforts as either radical or incremental, evaluate the success of the efforts
and attempt to prove or disprove the hypothesis based on the data from this internship.
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III. Application of Manufacturing Tools
A. Constraint Management in Core Sequencing
We first concentrated our efforts in the "shotgun" or core sequencing steps, which
includes DNA preparation and sequencing. This process is by far the most automated
section of the facility, with much of the laborious tasks performed by programmable
robotic arms and automatic dispensers. The core sequencing operation is summarized by
the following:
Cob *e pUC Picking/ pUC Sup pUC DNA
From "'Growing -10 Transfer Purification
Library Construction
Pla u s M13 Picking/ M13 Sup M13 DNA Sequence Run Seq. D ta
Growing -1'Transfer Purification Reactions Machines -
From To
Library Construction Assembly
M13 Picking/Growing
The raw material for this process comes in the form of plaques from Library
Construction. Plaques are made by spreading individual M13 phages (each phage has
some human DNA inserted into it) onto a plate coated with E coli (called "lawn cells")
and nutrients. The individual phages (Ml 3's) infected and burst neighboring lawn cells,
creating holes in the lawn of cells. Each plate contains from 50 to 500 plaques. Each
plaque corresponds to an original M13 that had a small piece of human DNA (about
2000-2500 base pairs long) inserted into it. The plaque is "picked" by touching it with a
toothpick or similar instrument, which transfers infected cells and phages onto its surface.
The instrument is then dipped into a growth media with E. coli, where some of the phages
are shed from the surface and allowed to replicate for about 16 hours at 37 degrees
Celsius. For a typical DNA fragment ("project") of 100,000 base pairs, 1200 of these
plaques are analyzed.
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pUC Picking/Growing
The raw material for this process comes in the form of colonies from Library
Construction. Colonies are made by spreading individual E coli cells infected with
plasmids (each plasmid has some human DNA inserted into it) onto a plate coated with
nutrients. The individual cells replicate both themselves and the plasmids they are
infected with, creating colonies (clones) of the original plasmid. Each plate contains
from 50 to 500 colonies. Each colony corresponds to an original plasmid that had a small
piece of human DNA (about 2000-2500 base pairs long) inserted into it. Each colony is
"picked" by touching it with a toothpick or similar instrument, which transfers infected
cells onto its surface. The instrument is then dipped into a growth media with E coli,
where some of the cells are shed from the surface and allowed to replicate for about 16
hours at 37 degrees Celsius. Towards the middle of the internship, for a typical DNA
fragment (also called a "project") of 100,000 base pairs, 1200 of these colonies are
analyzed. At the beginning of the internship most of the shotgun operation consisted of
M13's, with only about 10% of a project analyzed using pUC's, using about 2160 M13's
and 240 pUC's per 100k project.
M13 Supernatant Transfer
The cells in the growth media encourage the replication of the M13, which infects the
surrounding cells and eventually bursts them. The M1 3's end up in the supernatant phase
and they are isolated from the E. coli cells by "spinning" the growth plate down in a
centrifuge. 100 [pL of the supernatant is added to 10 ptL of 20% SDS solution
(surfactant), providing a stable solution for freezer storage. At this point, the samples are
in 96-well microtiter plates, where 16 well out of each plate (96 wells) are sampled and
tested for adequate DNA content for further processing. The test consists of running the
samples on gel electrophoresis, where the criteria to pass is to have less than 4 out of 16
with low DNA. If a plate does not pass QC, it is discarded and replaced with new
supernatant.
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pUC Supernatant Transfer
The cells in the growth media encourage the replication of the pUC-infected E coli. At
the end of the growth phase, the growth plate is spun down with a centrifuge and the
supernatant discarded. The resulting "pellets" are placed in 96-well microtiter plates
ready for purification.
M13 DNA Purification
At this point, the DNA is sent to the purification step, where the purpose is to isolate the
DNA from the rest of the growth material. This is done using a technique called SPRI
(solid-phase reversible immobilization), where under the presence of certain reagents,
DNA will bind to carboxyl-coated magnetic particles. When this happens, the original
solution can be discarded and the DNA washed with solvents. After the wash step, the
DNA is released from the magnetic particles and stored in an aqueous solution.
pUC DNA Purification
The purpose of this step is to separate the pUC DNA from the E coli DNA. This is done
using a proprietary technique developed at Whitehead. The end result is similar to the
M13 purification, with only the uncircularized plasmid DNA remaining, ready to be dye-
replicated using PCR.
Sequence Reactions
The purified DNA is now ready to be processed for sequencing reactions. One of the
methods used is the Sanger technique,10 where the DNA is replicated using PCR
technology in the presence of dye oligonucleotide primers. This causes a nested set of
end-dyed DNA to be produced. Since there are four bases in DNA (A, C, T and G), each
base has a different dye. Each microtiter plate (with 96 wells) is split into a 384 well
plate, the reactions performed and the 384 well plate "repooled"' back into a 96 well
plate. At the end of this step, the DNA sample is ready to be run through the sequencing
machines.
'0 An Introduction to Genetic Analysis, Anthony J. F. Griffiths et al, pp. 446-447, 6* edition, 1996 W.H.
Freeman and Company
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Sequencing Machines
The dyed-DNA sample is loaded into a "sequencing machine," made by Perkin-Elmer,
model ABI-377. The sequencing machine uses a combination of gel electrophoresis and
a fluorescence detector. Electrophoresis separates molecules in an electric field by virtue
of their size, shape and charge. If a mixture of DNA molecules is placed in a gel matrix
with an electric field applied to it, the molecules will move through the gel matrix at
speeds dependent on their size. The smaller molecules will move (elute) faster and so the
smallest string of the nested DNA set elutes first. There is a laser and a detector that
measures the fluorescence of the sample as it elutes. This provides an output similar to a
gas chromatograph, which is then interpreted using software. This machine is capable of
running 48 to 96 wells (samples) at a time in a period of about 12 hours (including run
and loading time), giving average read-length of about 800 base pairs or 1600 base pairs
per lane per day. Alternatively, the machine can be run in an 8-hour cycle time, but the
read-length drops down to 600, or 1800 base pairs of output per day per lane. which
makes for more difficult data assembly and processing. Although from a strict "output"
view, it would seem that it is better to run the machines three times per day, studies at
Whitehead showed much better assembly data (less "defects") from the longer read-
lengths, partially due to the long repeats region that are sometimes encountered. Thus,
Whitehead ran the 12-hour cycle. All of the data from these machines is sent to a central
data base, which collects data from all 2400 samples of the project and comes out with an
estimate of the sequence of the original DNA fragment (100,000 base pairs).
1. Manufacturing Scalability Model
One of the most important questions at the beginning of the internship was regarding the
scalability of the existing process. The operations management felt that although they
had a great deal of automation in place (accounting for about 25% of all unit operations)
and more automation under development, they wanted to know the effects of scaling up
their current model. The main philosophy was to keep the number of personnel low and
utilize automation to increase capacity. The sequencing machines were immediately
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identified and validated to be the bottleneck step, running 5 days a week, 24 hours per
day (5x24). The other steps were run in one shift and so had plenty of spare capacity for
the short-term needs.
However, there were many near-term changes in the works. The bottleneck step was
undergoing changes that would significantly affect the capacity of the entire system.
First, the number of wells per machine was increasing from 64 to 96 and the number of
machines increased from 19 to 40. This would effectively increase the bottleneck
capacity by a factor of three in the next six months. In the meantime, the ratio of M13 to
pUC's (plasmids), previously being 10:1, increased to about a 1:1 ratio, essentially
requiring a new automated purification process. In addition, the core sequencing step
picked up a lot of the finishing operation capacity, due to its economies of scale, adding a
degree of complication to coordinating and prioritizing daily operations. Lastly, the
operation had to have the capability of quickly changing reagent mixes, which due to
their high costs, were continuously being optimized. The model in its final form is
shown in Exhibits 1, 2 and 3, which are linked spreadsheets.
Exhibit 1 breaks down every manual or automated step and shows the setup and process
time for each, and estimates the labor required to perform each batch (which depends on
the batch size). Exhibit 2 then uses this information to summarize the labor requirements
for each major area of core sequencing.
Exhibit 2 is the master spreadsheet, which takes data from the designed bottleneck of the
plant, the ABI sequencing machines. The output of the ABI's is determined by the
number of machines assigned to core sequencing, the number of lanes run per machine
and the gel cycle time. The number of machines dedicated to core sequencing was set by
the total number of machines minus the number of machines down for maintenance at
any given time, minus the machines needed to run library QC, finishing and development
samples. Running at 96 lanes per machine took some time to implement because the gel
geometry was fixed, which decreased the lane clearance, requiring optimization of the
upstream and downstream processes. The gel cycle time was generally fixed at 12 hours,
21
although it was set up as a variable for further studies. Once the number of plates that
could be run per day was set, the batch size for each operation was set, which then gave
the number of batches per day required for each operation.
Exhibit 3 takes the information from Exhibit 2 and automatically generates a schedule of
events for each batch (called a "cycle" on the spreadsheet), estimating the amount of time
required to perform each major core sequencing operation. Exhibit 3 was particularly
useful in evaluating alternatives for one-shift operation by quickly pointing out when the
number of batches and associated cycle times exceeded an eight-hour day.
Exhibit 2 also linked the "coverage pattern", which is the number of pUC's (called DS
for double-stranded DNA) and M13's (called SS for single stranded DNA) per project
and the type of dye chemistry used in each (FP=forward primer, RP=reverse primer,
FT=forward terminator, RT=reverse terminator). The coverage pattern was determined
by Whitehead to have a radical effect on the number of gaps per project at assembly.
However, changing the coverage pattern implied changes in flows through core
sequencing, which then required operational adjustments.
The idea behind the model was to identify problems that may come up due to scale-up
and process changes, and to assess labor productivity.
2. Results from Manufacturing Scalability Model
The results from the model showed some significant future problems associated with
scaling the operation from 19 to 40 ABI machines, coupled with an increase in number of
lanes from 64 to 96 wells/machine (three-times increase in scale). The following findings
summarize the results:
0 Low utilization of personnel for the sequencing machines. At the time the model was
developed, the Center had gone from three eight-hour cycles per machine to two
twelve-hour cycles per machine with the same number of machines (19). Therefore,
the amount of labor required to operate the machines dropped by 33%. Further, the
labor efficiency with three shifts was about 70%. The model correctly predicted that
the existing crew could run twice the number of machines. However, this would
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require a turnaround time of two hours, which would mean that more people would
be required during the critical turnaround time (7 a.m. and 7 p.m.). This pointed out
that the shifts would have to be re-balanced or cross-trained.
e The picking operation was confirmed to be very labor intensive, utilizing 12% of the
labor costs. Although the picking operation had an existing automated picker, it was
not used due to technical problems. The labor utilization was already high in this area,
showing that the step increase in production would tax the existing crew. This
emphasized to the need to either get the existing automated picker on-line or scale up
the number of people doing this operation.
e The quality control operations took up a significant amount of labor (8% of the total),
emphasizing the need to rationalize it. The scheduling spreadsheet showed that, with
the existing rate of sampling, an additional partial shift would have to be added.
" The amount of work-in-process (WIP) inventory was significant, with over six weeks
in process compared to a cycle time of three days required with no WIP. This had the
effect of making it difficult to quickly see the effect of process changes, forcing
"short-circuiting" to get development runs through. Again, this pointed to the need
for evaluating and establishing a target WIP inventory.
" In addition, the model predicted that an additional shift would have to be added
(assuming no automation added to compensate) to the purification step and the
sequencing reaction step due to the increased number of batches to be run per day.
3. Outcomes from Manufacturing Scalability Model
The management of the Genome Center agreed with the insights as presented and agreed
to address the potential problems in the following way:
* Increase the cross-training amongst the sequencing machines operators, in order to
address the turnaround time problem and allow for better knowledge transfer that
would eventually lead to lower variance between machines and allow fairer allocation
of work. The allocation problem does not show up in the model, but the way the
sequencing machines were staffed, certain people did the gel prep work, while others
did the machine loading work, leading to some concern among the crew about having
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to do repetitive, narrowly defined tasks. There was a fair amount of interdependence
between tasks and it was difficult to account for the reason for gel problems due to
the separation of tasks. It was believed that if everyone had a set number of machines
assigned to them, they could do the prep work and loading and therefore have more
control over the process.
e Have the automated picker "Flexys" system sent back to vendor for repairs. After the
picker returned, it was found to be helpful, but not as efficient from a yield
perspective as doing the picking by hand, and it still suffered from technical glitches.
At the time, library construction (the source of raw material to the core sequencing
operation) was barely keeping up with production, and had become the new
bottleneck of the operation. Therefore, it was deemed more important to have high
library yields and this operation was kept as manual.
e The quality control issues warranted further investigation, the results of which are
shown in subsequent chapters. The final outcome was a reduction by 50% of the
labor needed for quality control.
e The amount of WIP inventory was a controversial issue, in that the shift supervisor
felt a need to keep buffers between steps to minimize the possibility of downtime.
The WIP inventory consisted of micro-titer plates stored in refrigerators after each
step of the process. There was about two weeks worth of production stored after
supernatant transfer, another two weeks after purification and two weeks of
sequenced DNA storage. Due to the small size of the samples, it was not perceived to
be a large problem, but as is well-known in operations management, served to hide a
variety of problems including machine unreliability and absenteeism. This problem
was especially exacerbated by the fact that besides the shift supervisor, there was only
one person trained to run the purification automation. The sequencing automation
had similar staffing problems, with only one person who knew how to run it. The
operations manager agreed to the concept of having an appropriate amount of
inventory. This issue was studied further and the results shown in subsequent
chapters. Due to the ramp-up of core sequencing output coupled with low library
construction output, core sequencing ended up running with low inventory de facto.
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e Finally, the management decided to speed up the automation in the purification and
sequencing reaction steps in order to have a "one-shift" operation. These changes
were implemented over a period of time and took up a considerable amount of
development time. The advantage of doing this was that it kept the development
personnel, who had to respond to production problems, from having to split up their
shifts to provide more than one-shift coverage.
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B. Variation Reduction
1. Core Sequencing Variation Reduction
Although the benefits of variation reduction were known to the Center, the variability in
their processes was not measured on a daily basis. Rather, the Center relied on large
excursions from the mean to react to problems. One of the reasons is that the processes
were almost never locked down and it was recognized that some of the processes were
not in statistical control. Variation reduction in core sequencing was considered
important because it provided a way to find throughput and quality problems. As
discussed earlier, the significant inventory levels created long lag times (1 day to six
weeks) between the source of variation and the final results. In addition, there was
inconsistent documentation using lab notebooks, making it difficult to "data-mine" at the
lowest operational levels. In an effort to better trace sources of variability, the following
plan was already being implemented by the Center:
* Structure documentation similar to that used in the pharmaceutical industry - SOP's
(protocols), batch or shift records and change control forms.
" Track machine reliability by manual documentation of failures and uptimes.
e Track key, relevant quality and output statistics for each project.
" Assign development efforts to address major sources of variation.
Outcomes for Core Sequencing Variation Reduction
e Documentation was improved over the existing lab notebook method, batch tracking
data sheets similar to current Federal Drug Administration (FDA) good
manufacturing guidelines (cGMP's) were used. Protocols were kept more up to date.
Change control remained less formal, due to the flexibility requirements of the
process.
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e Machine reliability tracking was more formal and closer management review than
previous, with a feed into the development group for fixing machine problems (most
of the machines were specified and installed by the development group).
* Key statistics were tracked on a daily basis, as shown in Exhibit 4, which was a
network-accessible file. Exhibit 4 was the main core sequencing tracking sheet, kept
updated by the relevant production leads. The tracking sheet was used to coordinate
amongst the various groups and provided management with a one-page summary of
project status. Exhibit 4 also summarized the quality of assembled data from each
project by the following metrics:
e Overall pass rates - percentage of "reads" of a project that were of acceptable library and
sequencing quality.
* Sequencing pass rates - percentage of "reads" of a project that were of acceptable sequencing
quality, implying that the "core sequencing" process described above worked successfully.
* Library pass rates - percentage of "reads" of a project that had adequate DNA inserted into the
sample.
* Average read length - this gives an indication of how long a string of DNA was read on average
for a given project. Generally, the better the quality of the data and the higher the pass rates, the
longer the read length.
* Gap data - after a project is assembled (all the reads done and compiled to get an estimate of the
DNA sequence), there were gaps that needed to be resolved. These gaps required manual
intervention by the "finishing" group, who had to find the appropriate strategy for resolving the
problem and then sent the orders to the lab to process the samples. This generally added a lot of
time to the project cycle and it was very desirable to minimize this. Generally, the better the
coverage (successful reads per base of DNA fragment), the lower the gaps. During the period of
the internship, the Center discovered that the right "coverage pattern" of pUC's, M13's and dye
chemistry provided the minimum number of gaps per project.
Exhibit 4 also shows the segregation between groups of projects as coverage patterns
or new technologies were introduced into production. The above metrics were
continually monitored to measure the impact of major process changes.
The final data for every project were available in a separate web-based system in
details ranging from aggregate project statistics down to the exact output of each
sequencing machine for every sample.
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Although the in-process data remained accessible only by the manual record keeping,
there were plans to have these data available for the next-generation automation
platform that the development team was working on.
* The variability of the above quality parameters was never formally measured,
although this was done on an individual basis for evaluating development projects.
The following table summarizes the variability of each quality statistic using data
from Exhibit 4. The variability of each statistic is measured using the Coefficient of
Variation (Cv), defined as the sample standard deviation divided by the sample mean.
Table 2 - Summary of Key Quality Statistics For Core Sequencing
Time period % OvI. Pass % Seq. Pass % Lib. Pass Read Lgth. No. Gaps
Mean Cv Mean Cv Mean Cv Mean Cv Mean Cv
1/98 - 30 projects 74 0.114 80 0.084 93 0.032 547 0.062 9 0.675
2/98-3/98 -20 projects 72 0.105 78 0.057 93 0.047 657 0.062 8 0.689
4/98 -14 projects 72 0.047 80 0.063 93 0.088 692 0.053 7 0.554
5/98 - 12 projects 87 0.070 93 0.046 94 0.022 777 0.039 N/A
As can be seen in the table above, there was a large increase in sequencing pass rates in
May, mostly due to addressing a recurring automation problem associated with the
purification system, which had the effect of decreasing variability as well. Although the
library pass rates had a steady mean due to the selection process (discussed in the Quality
Assurance chapter) imposed on the system, its coefficient of variability changed
significantly from month-to-month, by a factor of four from April to May.
The read length increase and variability decrease was due, respectively, to changing over
to twelve hour cycle times on the sequencing machines and an internal effort to improve
gel quality. The number of gaps per project dropped significantly during this time period
and continued to drop throughout the year due to the Center's focus on optimizing the
coverage pattern of projects.
2. Library Construction Variation Reduction
Library Construction is the step upstream to Core Sequencing, where the plaques and
colonies that contain the DNA fragments of interest are generated. The Center's
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management was concerned that this part of the production step would not be able to
keep up with Core Sequencing once they ramped up to full production. Core Sequencing
was scheduled to be capable of 50 projects per month by the end of the year while
Library Construction had averaged about 12 per month from January to May 1998. The
concern was not only with scaling the existing operation, but also improving its
reliability.
The following flowchart shows the library construction process:
New Project Shear & Size Select Ligate Transform o Core
(DNA fragT End Repair & Extract equencing
A project is a collection identical DNA fragments, originated and purified from bacteria
artificial chromosomes (BAC's) which are clones containing a piece of DNA
approximately 100,000 base pairs long. The goal is to break up the large fragments into
random, small pieces approximately 2000 base pairs long and package them up (ligate)
with a vector such as M13 or pUC. By ligating the fragments to a vector and infecting
host cells, known as competent cells, the plaques or colonies formed can be processed in
Core Sequencing.
Shearing and End Repair
Shearing of the large fragments is accomplished with an ultrasonic tip inserted into the
DNA solution for about 10 seconds at a set power setting. Shearing breaks up the DNA
into random sized pieces, but since DNA is double-stranded, a lot of the DNA end up
with ends that are single stranded. Single stranded DNA will not ligate and must be
"repaired", by adding mung-bean nuclease (MBN). MBN attacks the single-stranded
DNA ends by cutting them back until a double strand is found. The reaction is controlled
by specified time and mole ratios.
Size Select and Extract
The sheared and end-repaired sample is placed in an agarose gel matrix, using
electrophoresis to size select. Voltage applied across the gel box starts the migration of
the sample towards one end, with the smaller DNA molecules travelling faster. A marker
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of DNA of known length is run at the same time. The end result is a gel streak that can
be cut out to select DNA sizes of a certain range (1.6 to 2.4 KB). The first "cut" is then
re-processed using the same procedure to get a second cut with a narrower range (1.8 to
2.2 KB). The second cut is then extracted using solvents to clear out any gel remnants
and end up with a pure DNA sample, which is tested one more time before ligation.
Ligate
The next part of the process is ligation, where the DNA is fused or packaged with a
vector (M13 or plasmid) under certain conditions. The efficiency of this step is a
function of many variables including reactant and enzyme mole ratios, ligase activity and
time. The reactants are the DNA fragments and the vector. The enzyme is ligase with a
buffer to provide ATP for the reaction. The reaction is carried out at 16C overnight.
Tranform
Tranformation is the process by which the ligated vector (vector with DNA insert) infects
a host organism in order to replicate it to have enough pickable cells. This step also
separates the ligated vectors from each other and unligated vectors. If the ligation and
transformation is successful, there will be enough infected hosts to provide an adequate
"coverage" of the project (at least 2400 colonies or plaques for a 100 KB project). The
ligation/transformation is quality controlled by performing a "Plating QC," where about
10% of the ligated material is transformed. If enough pickable colonies or plaques form
(at least 240 for a 100 KB project), the project is deemed adequate as far as coverage and
the test transformation is sent on to production for Sequencing QC (discussed in the
Quality Assurance chapter). If the test transformation passes the Sequencing QC, the
entire project is transformed (also called "plated out", since the transformation process is
done on agar plates).
a) Approach to Variation Reduction and Throughput
Improvement
In July of 1998, we met to discuss an approach and the following points and questions
were posed:
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e The process seems go through periods of spectacular success and failure. If the
process could be made to run like it does during the successful periods, there would
be plenty of capacity to provide for production. Since the process was purely
biological (reagents and raw materials), there were many sources of variation. What
are the sources of variation? How can they be reduced?
e The lead lab technician for this step was leaving within a month, what was the best
strategy going forward?
e Are policies and procedures appropriate? Are they being followed?
b) Initial Assessment of Library Construction Process
One of the things that stood out in this process was the tremendous amount of rework that
occurred. The rework was routed at the two main QC points: Plating QC and Sequencing
QC. Plating QC, part of the Transformation Step, was performed by the Library
Construction team and since 50% of the projects failed at that point, compared to 25%
failure rates at the Sequencing QC step, it seemed to be a good potential starting point.
Library Construction was functionally organized, with one lead lab tech who evaluated
the Plating QC results, collected Sequence QC data, ordered and tested raw material,
assigned daily tasks and filled in when needed; one lab tech who did the first three steps;
and two lab technicians that performed the transformations. Since the lead lab tech was
leaving soon, it was considered important to understand her decision process for Plating
QC. After discussions with the lead tech, it was clear that she used her experience and
tacit decision rules to deem whether a project would pass Plating QC. We decided to
develop a more robust model that took into account more of the available lab data in
order to make more consistent decisions.
c) The Plating QC Process
The following outlines the existing Plating QC process:
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" A test transformation was done, giving a number of white plaques and blue plaques.
The white plaques presumably were vector with a DNA fragment and the blue
plaques were vectors with no fragment (also called empty vector).
e The white and blue plaques were then counted and as long as the white to blue ratio
was deemed high enough (5 to 10, depending on how other transformations were
working that week and production urgency) and there were enough whites to cover
the project, the project was approved. Historically about 50% of projects passed test
transformation.
e If a project did not pass, it was sent back to be retransformed, religated or completely
reprocessed (again, depending on the conditions at the time).
We wanted to find a better and more quantitative tool to use for Plating QC because we
felt that if the QC could be made more accurate and less variable, there would be less
Type I errors (rejecting when the sample was acceptable) and thus higher throughputs
through the system. Further, we wanted to reduce the variability in output due to
changing QC test parameters.
d) Use of Controls in Library Construction
For every project that was transformed, there were three controls that were supposed to
be run:
Vector alone - to check that the vector, lawn and competent cells were not contaminated.
Vector + Ligase - vector was treated so it would not ligate onto itself - this would check
that this was true, gave a baseline of blues and whites to which the main sample could be
compared
Vector + Ligase + Calf Thymus (CT) DNA - a known DNA fragment from Calf Thymus
was ligated to the vector and it was expected to give a large number of whites, this
checked the ligase activity.
The sample itself was run with Vector + Ligase + Project DNA.
We found that some of the controls were not run and the ones that were run, not well
documented. The missing controls made it difficult to pinpoint Library Construction
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problems when they occurred. The Library Construction management re-emphasized to
the laboratory technicians the importance of controls, which alleviated the problem. The
ideal Plating QC procedure would incorporate some or all of these controls in the
decision process.
e) Development of a New Plating QC Predictor
One of the purposes for Plating QC is to be able to predict the percentage of white
plaques that would end up with no DNA fragment. These plaques were also called
"empty vector" or "Seq Vector" and it was desired to have less than about 8% of these
per project. The other purpose for Plating QC is to estimate the yield of plaques from a
particular project in order to verify there will be enough plaques generated to "cover" the
project (recall that about 1200 plaques are required per 100 KB project). Since, except for
variability in Plating QC, it was relatively easy to determine the yield of the
transformation, we concentrated on finding a better predictor.
We first classified the white plaques into two categories:
(1) W = Wf + Wv, where
W= total number of white plaques from sample,
Wf = number of white plaques with a DNA fragment and
Wv= number of white plaques that are empty vector
(2) Wv/W *100% = Percentage of Empty Vector
However, since it is not possible to tell which of the white plaques are empty vector, we
used the Vector+ Ligase control to estimate it.
Let B= number of blues plaques from sample,
Wc= number of white plaques from control and
Bc = number of blue plaques from control
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Now we know that if the transformation had been equally efficient for both the sample
and the control, B would equal Bc. However, this is not usually the case, but we can use
the ratio of B to Bc to get an idea of the relative efficiencies. Similarly, Wv would equal
Wc if the transformation efficiencies were the same. However, their relative efficiencies
can help us establish the following relationship:
(3) B/Bc=Wv/Wc= Es/Ec, where
(4) Es = sample transformation efficiency and
(5) Ec = control transformation efficiency.
Solving for Wv,
(6) Wv=Wc(B/Bc) and substituting into equation (2) gives us:
(7) % Empty Vector-(B/W)(Wc/Bc) * 100%
Thus, we had a quantitative predictor that we could use for Plating QC and that utilized a
closely associated control.
f) Correlation of New Empty Vector Predictor for Plating
QC
We attempted to apply the data we had available to run a linear regression of equation
(7). The two independent variables were B/W and Wc/Bc, both obtained from plating
QC data from all 39 projects from June through August for which we had data. The
dependent variable, % Seq Vector, was obtained from Sequencing QC data. The
regression is plotted in Exhibit 5, showing a good correlation to % Seq Vector (SV-
Empty Vector). Theoretically, the coefficient of the regression should have been 1, but
instead we obtained a value of 0.5, with a 95% confidence of 0.4 to 0.6. Although we
did not find a reason for the difference, we found that the equation correlated better to the
dependent variable being % Seq Vector + % Small Ins. % Small Ins is the percentage of
very small DNA inserted into the vector. The new regression showed a better correlation
and a more reasonable value for the coefficient (1.2), with the theoretical value of 1
34
falling within the 95% probability limits. The ability to predict %SI along with %SV was
considered to be an advantage and although our theory did not predict this would happen,
we decided to use it as an empirical tool anyway, since it was considered to be better than
the current method.
g) Reducing Variation of the New Predictor
The next step was to try to reduce the variation of the predictor itself. We made the
hypothesis that B/W and We/Bc were independent, ran a linear regression between the
two variables and found no correlation between them. Since our predictor is a product of
two independent variables, the coefficient of variability of our predictor could be
estimated using a method discussed by Himmelblau"I:
For a general equation involving a product of many variables,
Y= a*X1*X2...Xn,
Where, "a" is a constant, XI is factor variablel, X2 is factor variable 2, and Xn is factor
variable n, Himmelblau shows that
(Cv,Y)^2 = (Cv,X1)^2 + (Cv,X2)^2 +...+ (Cv,Xn)^2, where
{Cv,Y} is the coefficient of variation (Cv) for the variable Y, {Cv,X1 } is the Cv of X1,
{Cv,X2} is the Cv of X2, and {Cv,Xn} is the Cv of Xn.
Applying the above equation to our predictor gives us:
(Cv,SV+SI)A2 = (Cv,B/W) A2 +(Cv,Wc/Bc) A2,
We noticed that since the control usually resulted in a low number of blues (Bc) and
whites (Wc), with values ranging from 1 to 10 and 5 to 50 respectively, the low counts
could be contributing a high proportion of the overall variability. We further assumed
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that Wc and Bc are binomially distributed, that is, for any given sample of the vector,
there is a constant fraction of blue (p) or white plaques (1 -p) that would appear.
Assuming the controls Wc and Bc are binomial, a way to reduce the Cv,Wc/Bc term is to
take a larger sample. Recall that:
Cv= Sx / X , where Sx is the standard deviation and X is the mean of the distribution.
And for a binomial function,
X = np and SxA2=np(1-p)
where n is the number of outcomes and p is the probability of the outcome.
Therefore ,
(Cv)A2= (1 -p)/np , and as the number of outcomes increases, the square of the coefficient
of variation decreases and therefore so does the contribution of variability from the
control.
Reducing the variability from the sample (B/W) would be more difficult, as there were
many more potential contributors to it. After some discussion with management, we
decided to try the following plan to reduce variability:
e Update protocols to reflect existing practice.
* Perform more formal cross-training.
* Keep more accurate batch records.
* Gather process data to find correlation with failures.
* Stricter adherence to protocols and controls, be more consistent with process times
and batch sizes.
The following table summarizes the variability found in Library Construction over the
time these changes were implemented:
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"Process Analysis and Simulation - Stochastic Systems" D. M. Himmelblau, University of Texas at
Austin, 1969 pp. 38-39.
Table 3 - Summary of Variation In Library Construction
Time period B/W B/W Wc/Bc We/Bc
Mean Cv Mean Cv
June-Aug, 1998 (167 samples) 0.71 1.79 0.61 0.94
September, 1998 (73 samples) 0.43 1.38 0.28 0.56
October, 1998 (96 samples) 0.39 1.00 0.39 0.74
November, 1998 (63 samples) 0.48 0.82 0.35 0.36
November, 1998 (11 HS samples) 0.08 0.88 N/A N/A
The mean B/W ratio for the months of September through November did not change.
However, the coefficient of variation decreased from approximately 1.4 to 0.8 in the
same time period, indicating that there was some reduction in variation. The mean Wc/Bc
ratio remained relatively constant from September to November. The Wc/Bc coefficient
of variation did not show any clear trends indicating either an increase or decrease in
variability. In November, a new procedure (Hydrashearing- HS) for processing the DNA
was implemented on a trial basis and showed great promise, as shown by the dramatic
decrease in the mean value. A decrease in the B/W ratio is desirable, since it indicates
more whites per unit blue. Although the new procedure had about the same coefficient of
variation as the old procedure, its standard deviation was much lower (due to reduction of
its mean value).
h) Effect of Variation Reduction on New Predictor
One would expect the decrease in B/W and Wc/Bc variability to enhance the ability to
predict the %SV+SI in the samples. However, this did not prove to be true, with the
predictive model actually decreasing in performance during the period of September
through November. This loss of predictive performance indicates that there were sources
of variation that were not being predicted by solely B/W and Wc/Bc. Since the new
Hydrashear procedure looked very promising, little additional effort was made to find out
the additional sources of variability.
In addition to finding a better predictor of project success, we tracked the effect of
variation reduction program on output. Table 4 summarizes the output from library
construction. The new predictor was placed in effect in September and the percentage of
projects that passed Sequencing QC increased dramatically from historical (93% vs
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75%). Unfortunately, many of the projects failed the "Overlap (O/L) Test "at that time,
meaning that the project already overlapped an existing project, decreasing the number of
projects actually delivered to Core Sequencing down to 27. In October, compounding the
problem of overlap (only 42% of projects that made it through Sequencing QC passed the
O/L test that month) was a marked decrease in percentage of projects that passed Plating
and Sequencing QC. The Sequencing QC predictor was still working better than
historical (June-August), but not as good as in September. The reason for the loss in
predictive ability was not found, although there were a fair number of new vectors and
reagents introduced that month. The library construction yields decreased further in
November, with even less projects passing Sequencing QC. Library Construction had
gone through a period of success followed by a period of failure. The exact reasons for
these were not found during the internship, although the new hydrashear procedure
promises to reduce variability significantly, which may help shed light on this subject in
the future. As can be seen in the "November-H" period, which are the hydrashear
projects done in November, the number of projects passing plating QC was 100% and
only one out of 11 of these failed to make it through Sequencing QC.
Table 4 - Library Construction Statistics
No. New No. Pass % Pass No. Pass % Pass No. Pass % Pass Overall Seq QC
Period Projects Plating Plating Seq QC Seq QC O/L Test O/L Pass Pass
QC QC Test Rate Rate
June 69 34 49% 26 76% 25 96% 36% 38%
July 55 37 67% 28 76% 23 82% 42% 51%
August 43 16 37% 6 38% 4 67% 9% 14%
Sept 73 43 59% 40 93% 27 68% 37% 55%
Oct 96 40 42% 29 78% 12 42% 16% 33%
Nov 61 26 43% 11 42% 11 100% 18% 18%
Nov -H 11 11 100% 10 91% 10 100% 91% 91%
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C. Organizational Structure
1. The Challenge of Functional Organizations
According to Hayes, Wheelwright and Clark (HWC),12 the modem business organization
is based on two principles:
* Divide and Conquer - First enunciated by Julius Caeser two thousand years ago,
where specialization is needed to be more efficient and line activities are separated
from staff activities.
* Responsibility Equals Authority - A manager responsible for a certain scope should
have the authority to commit the resources needed to accomplish the project.
The use of these principles creates a functional organization, where individual groups
reporting to one manager are responsible for a particular function such as production,
quality, maintenance, engineering, scheduling, materials management or purchasing.
HWC argue that such an organization works well in a relatively stable business
environment (5-10% productivity improvement per year), but when major improvements
are needed simultaneously among several dimensions, the organization may not respond
to well to such problems.
A general illustration of the functional problem occurs when the production group is
made responsible by upper management to reduce costs. The production group may
decide to lower costs by reducing the amount of preventive maintenance on their
equipment. When the maintenance group is approached with such a proposal, they may
resist because they are measured on cost of equipment failure, which they feel will
eventually increase by suddenly downsizing PM program. In order for both sides to
come to an agreement, they must both collaborate to share the risks and rewards,
requiring an alignment that is difficult to negotiate if one party has asymmetric decision
power.
12 Dynamic Manufacturing, R. Hayes. S. C. Wheelwright and K. M. Clark, The Free Press, NY, 1988, pp.
96-129
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2. Solving the Functional Organizational Problem
HWC proposes that a central staff can be used to get through the organizational barriers
by auditing; evaluating performance; communicating goals and objectives; coordinating
and prioritizing; consulting; management training; and advancing process development.
Another way of solving the problem is to adopt a process orientation to plant needs. For
example, a plant may be organized such that a manager and the people reporting to her
are responsible for a particular function (production, maintenance, etc.). A plant may
also be organized such that a manager is in charge of a particular shift or group of people
that does a particular process (it does not matter if they are all doing the same process or
are on the same time shift). The advantages of process orientation is that it cuts across
the organizational barriers, broadens manager's and worker's perspectives and allows for
better learning between steps (similar to the advantages of Intel's "copy exactly"
philosophy). However, the economies of scale must provide for the creation of distinct
groups and the process must be relatively stable before doing this. The figure below
illustrates the difference between process (horizontal shading) and functional
organizations (vertical shading). Note that both types of organizations fulfill the two
main principles of "Divide and Conquer" and "Responsibility Equals Authority".
Team/Function :toe Maintenance Eng/Dev QA
Shift 4
3. Organization of the Center and Effects
At the beginning of the internship, the Sequencing Center was very functionally driven.
As the internship progressed, the center moved to a more process-oriented management
approach. The main places observed were the interactions between Library Construction,
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Core Sequencing and Development. The Center had the following functional groups
during the internship:
Mapping - conducting the main planning work of DNA sequencing including finding
markers and preparing project-size DNA fragments that were roughly mapped.
Library Construction - taking the project DNA fragments, replicating, shearing, size
selecting and packaging into recombinant form ready for core sequencing.
Core Sequencing - receiving the many small recombinant organisms that encompass a
project processing and sequencing each one.
Finishing- obtaining the data from the Informatics group, identifying non-existent or
questionable sequenced regions ("gaps" in the original DNA fragment) and doing
laboratory work to prepare samples required to resolve problems.
Informatics - running both the IT infrastructure and software/hardware required to
process and store the sequence data. Processing the data from the Core Sequencing and
allowing access to the data by the different areas.
Materials Management and Infrastructure - staffing the stockroom, taking care of
facilities, ordering supplies.
Development - executing new process or process improvement projects.
Each one of these groups had their own manager, usually a PhD or Masters level scientist
specialized in a particular technology. There seemed to be alignment of objectives at the
top and middle management levels, helped by the weekly staff meetings and daily
discussions. As is observed in many manufacturing sites, there was less alignment of
objectives and priorities at the factory floor level, due to the larger group size, more
functional division and lack of forums at which to discuss and resolve problems.
An example of the central group working well together when the Center realized that a
combination of M13's and pUC's gave the best sequencing results, with minimal number
of gaps. The entire group was agile and flexible enough to convert to the new process in
a matter of months.
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An example of organizational discord was the lack of balance in the types of projects that
the development group was working on - they seemed to be top-driven, at first with little
input from the core sequencing or library construction personnel, who were their main
customers. The development group was in charge of specifying new equipment and
building new automation and did so very efficiently. But many of their platforms had
glitches which they did not have the time to fully address but caused a major amount of
automation "babysitting" that core sequencing personnel had to do in order to quickly
react to unexpected problems. As a result, the operations personnel could not just set up
a batch and walk away from it, they had to stay pretty close to the machinery, limiting
them from performing other tasks in parallel. Although this particular problem was a
resource allocation issue, in that management deliberately wanted the group to focus on
breakthrough projects, it nevertheless created some questions at the factory floor levels.
The central question related to the balance between running fast and efficiently or versus
working on the next-generation systems.
4. Assessment of Core Sequencing Organization
As a result of gathering data for the initial scale-up modeling for Core Sequencing, as
well as form the results derived from the model, a number of potential areas of
improvement were outlined.
In order to understand the context of the suggestions, the following summarizes the
organization of Core Sequencing as it existed at the beginning of the internship:
The shotgun sequencing steps were organized hierarchically, with two groups of
laboratory technicians, each headed by a more senior laboratory tech. The senior techs
reported to a laboratory supervisor, who reported to the operations director. The
responsibilities of each group are outlined below:
Senior Lab Tech I Senior Lab Tech 2
2 techs 1 tech 1 tech 7 techs
Picking/ Supernatant DNA Sequence Run Seq.
Growing Transfer Purification Reactions Machines
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The main strategies for improving the factory floor personnel productivity included:
e Initiate cross-training. This came directly from suggestions outlined in the
Manufacturing Scalability (meet gel machine cycle times), Inventory Management
(minimize downtime by having more than one person able to run the automation) and
Variation Reduction (standardize work and transfer knowledge) studies.
e Operate seven days a week, twenty four hours a day (7x24). In order to better utilize
the existing infrastructure and to provide pressure to improve robustness of processes.
" Initiate team skills training. In order to go to a 7x24 operation, the teams would need
to learn to rely on each other when management was not available to help them make
decisions. In order to minimize problems due to poor team dynamics and additional
"decisional" pressure imposed on the teams, the Center needs to invest in professional
coaching and interpersonal skills training. There was also a technical component of
skills training required to do continuous improvement work. The Center should invest
in building the skills of their existing trainable personnel in order to improve their
productivity.
" Change incentives and structure. The structure at the Center was modeled after the
labs that Whitehead and MIT run. The hourly rate was relatively low, creating
turnover of the most highly skilled personnel. The pay system was set up so people
would get raises if they moved up the management ladder, creating horizontal layers
and disenchantment due to the perceived limitation of upward mobility. Companies
have found that paying for skills can become a powerful incentive for cross-training
with even modest differences in pay. In organizations that require flexibility and
technical skills, there are tradeoffs between having a few good people at a higher
salary and having many people with low salaries.
e Training in process improvement work. The personnel at Core Sequencing had very
little concept of learning curves, continuous improvement, and control charts. By
actively involving them in making decisions about how to improve the process, they
would feel more ownership and motivated to do their jobs better. This would also
take some of the pressure off the development team to find improvements.
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5. Outcomes of Core Sequencing Organizational Assessment
e The sequencing machine team started cross-training and evolved from having specific
people wash and reload the gel plates to having everyone trained on the entire
process. Further, they took on the tasks of gel-tracking, that is, taking the gel image
output and checking/releasing the gel for further processing. As discussed in the
previous sections, cross-training led to a reduction in variability and an increase in
productivity, providing a good example of the benefits of moving a team from a
functional to a process focus.
e The use of 7x24 shifts is still under consideration, but not implemented during the
internship due to concerns about management supervision on weekends. However,
some weekend work is nevertheless done unsupervised on an as-needed basis.
e Team skills training was not started because the Center decided to keep a hierarchical
human resource policy.
e The Center changed the incentive structure for lab personnel by offering more
competitive wages. Although the amount of pull from the industry at the time was not
high, this could easily change if the local biotechnology companies continued to
grow.
e Training in process improvement work was not done, since the development team
was viewed as primarily responsible for improvement work. The perceived value of
training lab personnel was low and any major suggestions would have to go to the
development team to be implemented. However, "ad-hoc" improvement work was
done by suggestions at the lab tech level that were brought to the attention of
management. For example, in library construction, there was a suggestion to go to
larger format plates, which was approved and implemented almost immediately.
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D. Quality Assurance
Despite the desire to eliminate in-process testing by building the quality into the system,
quality assurance (QA or QC) is a necessary evil in most processes. QA is used to avoid
incurring additional processing costs on defective parts. Since it is usually not cost-
effective to do 100% testing, a "batch" of the process can be sampled and if the quality is
not deemed to be high enough, the entire batch is discarded. At the Whitehead Institute,
there were many quality checkpoints that occurred at various parts of the process. We
studied three of these in detail, to rationalize the threshold values and necessity.
1. Quality Assurance in the Core Sequencing Step
As discussed earlier, the bottleneck of the core sequencing step was the ABI
(sequencing) machines. The Center's management desired to maintain a one-shift
operation and to avoid adding personnel, even with a projected ramp-up to 40 machines.
We also mentioned that quality control (QC) in the core sequencing step took up about
8% of the total labor costs (Exhibit 2-"QC Options"). These labor costs did not include
quality control of the final product (gel tracking and approving). The first quality check
step at the Shotgun Sequencing was after Supernatant Transfer and consisted of taking 16
samples out of each plate (96 clones) and running them through an agarose gel
electrophoresis. The presence of DNA was detected by ethidium bromide, which in the
presence of DNA, glows under UV light. The costs associated with doing the check
included reagent costs, set-up cost for the gel, actually running the gel, taking a
photograph, logging in results, discarding the gel and cleaning up the "gel box" for the
next run. The mean failure rate at the supernatant transfer step was 1%, meaning that 1%
of the samples would fail QC. An identical test was done after the DNA purification
step, with a mean failure rate of 2%. An analysis using the Operating Curve concept 13
revealed that the Center could cut down their sampling to 8 per 96 wells with very little
increase in Type 1 error (rejecting when the sample is acceptable), as shown in Exhibit 7.
Exhibit 7 compares sampling 8 versus 16 wells. For example, given that the proportion
13 "Production and Operation Analysis", Steven Nahmias, p.680, Irwin, 1997
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of defects in the lot was 2%, the probability of accepting the lot is 99.97% (probability of
rejecting is 0.03%) with 16 samples, whereas the probability is 98.86% (probability of
rejecting is 1.14%) with 8 samples. The costs associated with the slight increase in Type
1 error was offset by the savings associated with less testing. Although net savings of
$16,000 per year was projected, the Center could save as much as $24,000 per year by
eliminating sampling altogether. However, since the sampling caught systematic errors
that came up from time to time (for example a machine going out of calibration and this
not being detected), it was deemed prudent to continue sampling at the lower level.
Analysis revealed that the process would sometimes go out of statistical control and
therefore this safety measure would catch the problems before they went on to the more
expensive Sequencing reactions step. Since the automation platform was constantly
being optimized for output coupled with a lack of a comprehensive preventative
maintenance program (due to limitations in development resources), engineering the
quality into the system was not considered at the time.
2. Quality Assurance in the Library Construction Step
As the Core Sequencing step started ramping up in scale, the Library Construction step
was quickly becoming the new bottleneck of the Center. Further, due to the challenge to
the project by private investors (Perkin-Elmer's Celera), the need for finished projects
became less pressing, while the need for sequence data to get a "rough" version of the
Human Genome increased. The following flowchart shows the main steps in Library
Construction:
Library Construction QC Process:
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As discussed in the Variation Reduction chapter, once a project passes the Plating QC
step, the colonies (plaques) go on to a more elaborate test, where it is actually run through
the Core Sequencing step as a trial. The Sequencing QC step tests for three things:
Empty Vector (meaning no DNA inserted into the vector), Small Insert (very small pieces
of DNA inserted into the vector) and E. coli (meaning DNA from E. coli rather than
human was sequenced). If the aggregate amount of defects for the test plates exceeds a
certain threshold (8% at the beginning of this process), the project is rejected and the
library construction process must be started over again. We found that the rate of project
rejection at the Sequencing QC step would be about 45% if the criteria of 8% were
seriously followed. However, in an effort to keep the Core Sequencing running,
exceptions were made and projects were passed that were above this threshold, resulting
in about 75% of the projects passed. In order to find the true most cost-effective
threshold value, we decided to build a cost-based model (shown in Exhibit 8).
Cost-based model of the Sequencing QC step
The premise of the model (Exhibit 8) was to determine the cost of library quality. Library
Histogram of Library Quality (March-July 1998, 91 samples)
16%
14%
.2 .~
12%
10%
'8 8%
6%
4%
Fraction of Library Defects
quality varied from project-to-project, as shown by the histogram above. The cost of a
library could be broken down into the cost of generating a library and the cost of lost data
due to low library quality.
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Ideally, a project was generated at an incremental cost of $1325 (labor, reagents). Even if
this project passed Sequencing QC, as outlined above, a certain fraction of its data, D,
would be unusable due to defects associated with library construction. The cost of
sequencing a plate is $225 each and each project has about 30 plates. Therefore, the cost
of library generation and lost sequencing data for D=0. 10 is:
$1325 +$225*30*0.10= $2000, where D is the fraction of the project
However, one can reduce the cost of lost data by screening out libraries above a given
threshold, which has the effect of producing libraries of higher quality. An example of
this is shown above from a sample of libraries taken from a given period in time. The
mean of the distribution shown above is 0.10 (10% defects). If all of the libraries with
defects rates above 11% (0.11 fraction) are screened out, the mean of the truncated
distribution drops from 0.10 to 0.08.
However, screening will cause more libraries to be rejected and it is shown below that the
cost of library generation will increase due to "recycling" of projects within Library
Construction:
Rejection rate, R
Library Generation
Rate of new projects ($1325 per library) -Rate of new to Library
Construction, F to Core Sequencing, P
At steady-state, F = P, the rate of new libraries introduced into the system equals the rate
that leave the system.
F+R = L, library generation rate, the rate that libraries must be generated to account for
both the new ones and reprocessing of the existing ones.
Let r = R/(R+F), the fraction of libraries that are rejected.
Therefore R= r (R+F) or
R(1-r) = r F or
R = F(r/(1-r))
Therefore, L = F(1+r/(1-r))
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Therefore, for a rejection rate of 5% that gives a mean project defect rate of 8% (from the
sample given above),
L= 1(1+0.05/(1-0.05))=1.053
The costs to generate one library becomes:
$1325*(1.053)+$225*30*0.08=$1395+540=$1935.
One of the key functions of the equation is the rejection rate due to the threshold used. If
the same screening threshold gives a 10% rejection rate, then the costs become
$1325*(1.111)+$225*30*0.08=$1472+$540=$2012.
The last part of the cost model accounts for the fact that if the data from sampling was
completely reusable, a project could completely recover the costs of the extra sequencing
required by rejected samples by simply running a lower "coverage" rate. Often, a library
that is rejected has such poor data that it is not used in the final assembly process. To
account for this loss of data, the model assumes that once a library is rejected, only about
50% of its data are recoverable, which means that the project has incurred additional
costs due to lost data. The lost data costs can be estimated by R*$225*50%. Since R
=F(r/(1-r)), on a unit cost basis (F=l), the lost data cost is:
$225*0.053*0.5=$6 for the second example and $225*0.11*0.5=$12 for the third
example.
The three examples give values of $2000 (taking the distribution as given), $1941 (11%
cutoff and 5% rejection) and $2024 (11% cutoff and 10% rejection). Clearly, there is
some value in going through the exercise of finding the optimum threshold value of
rejection.
The threshold used for rejection gives different rejection rates depending on the sample
size. Using binomial theory, one can estimate the rejection rate at a given mean value of
the sample. All of the factors discussed above are shown in Exhibit 8 for three different
sample sizes. We used Crystal Ball to set up a Monte-Carlo simulation of these events
assuming a fitted log-normal distribution of library failures.
Outcome
The results from the simulation appear in Exhibit 8, showing that costs increase
significantly as the threshold value of is decreased. However, there are diminishing
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returns to increasing the maximum acceptable levels. Having no limit actually is
problematic, in that libraries with high percentages of defects create assembly and
finishing problems not represented in the model. In particular, data assembly problems,
shortage of coverage for projects and added logistical complexity start becoming a large
factor at library qualities with higher than 15% defects. The model also validate thoughts
that there should be three test plates per QC, showing a sharper drop to the minimum cost
level, although higher costs if the threshold value is low. The Center decided to use 12%
as the new, official threshold, theoretically dropping their Library Construction costs
from $3686 to $2137 per library. At the high levels of throughput (50 libraries per
month), this could result in savings of up to $929,400 per year. However, most of the
time the 8% rule was already being by-passed.
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E. Inventory Management
Motivations Behind Holding Inventory
The classical reasons for holding inventories are14
1. Uncertainty of supply and demand
2. Setup costs
3. Speculation
4. Transportation
5. Smoothing
6. Logistics
7. Control Costs
Although these motivations are relevant to different extents, there is an additional
motivation not mentioned in Nahmias, which is to balance throughput with development
speed. There is a need to maintain a minimum amount of inventory in order to avoid
shortages and subsequent downtime. However, if the amount of inventory is too high, it
increases the ramp-up time for development efforts. This concept is one of the reasons
the JIT system is successful, it allows quick identification of problems (cause and effect)
due to less lag time in identifying and minimizes the amount of defective inventory when
a process problem occurs. However, implementing JIT requires a large amount of
management and supplier commitment. At this stage of manufacturing capacity
development, it was clear that JIT would be difficult to implement correctly. Therefore,
we decided to look at inventory levels at the Core Sequencing step in order to find an
optimum.
Core Sequencing Inventory Model
The Core Sequencing step had various places where work-in-process inventory (WIP)
was accumulated. Further, each processing step had different mean daily capacities and
variances. The daily capacities were influenced by raw material availability, staffing and
" "Production and Operation Analysis", Steven Nahmias, p.213, Irwin, 1997
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machine uptime. The first four steps were particularly vulnerable to absenteeism, due to
the specialization of the labor functions. As a result, the lead technician tended to keep
an inventory of two weeks of production between steps, adding up to six weeks of
inventory in the system. Correspondingly, any new process improvements would take at
least that amount of time to make its way through the system. In order to minimize the
time to test new processes, the inventory (FIFO system) was bypassed on an as-needed
basis. However, full implementation still required eventual replacement of the entire
inventory.
DNA Pick/Grow Sup Transfer Purified DNA Seq DNA ABI WIP Data(1 day) (2 weeks) (2weeks) (2 weeks) (0.5 days)
The model used data obtained from the current operations to determine the throughput
pattern of each step (Exhibits 9-12). Each of the Exhibits 9-12 has a 110-day sample of
daily throughput data for the particular step. The data were then sorted as a histogram
(shown on each exhibit) in order to simulate the variability on output for each step.
Based on the histogram, assuming that the distribution will not change, we built a
stochastic model and ran simulations with varying days of inventory at each step. The
model (Exhibit 13) assumes that each particular step has a max-min inventory level. The
step would either run or not run depending on the inventory level. Each step was
assumed to be capable of its design throughput. The actual throughput of the step would
depend on a "multiplier", which had the pattern from the original histograms imbedded.
Therefore, even if a step "ran" on a particular day (due to low inventory levels), its
throughput would be random and bounded by the histogram pattern. The output for the
entire process was linked to the variability of throughput of each individual step. At any
given time, if its raw material inventory levels dropped below zero, the final step's output
could be zero. The monthly output could be characterized as a percentage of theoretical
(uptime).
The results of the simulation are shown below, where as expected, the percent uptime
increases with inventory, to a point of diminishing returns. For this particular process,
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the 99% uptime was set at 11 days of inventory, compared to the
days of inventory.
0D
E
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Effect of Aggregate Inventory Levels
on Process Uptime
5.0 10.0 15.0
Days of Inventory
20.0
Outcome
The inventory reduction model was used to point out that the optimum inventory was far
below that used in practice. Although the levels of inventory were not formally
controlled, there was greater awareness of the effect of having large inventories on the
speed of development, which was an important part of the ramp-up process. After this
model was developed, inventory levels dropped due to low input rates from Library
Construction, so inventory levels remained low. Future plans called for the next-
generation automation system to replace many of the labor-dependent operations that
create the variation in output for each process. However, it was also noted that by cross-
training personnel on Core Sequencing, the group would have more flexibility to shift
resources to the critical step as required.
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IV. Process Development Decision Support Hypothesis
A. Hypothesis
The hypothesis is that high variation processes are more conducive to improvement
through radical improvement efforts rather than incremental. The variability of processes
can be described by their outputs using the sample coefficient of variation (Sx/X) to
classify them. If a process is classified as high variance, the resources required to do
incremental improvement are better utilized on radical improvement efforts, assuming
that basic scale-up data are available. If a process is classified as low variance, the
resources may be better spent on incremental improvement to take advantage of learning
curve effects, assuming that scale-up data are available. These decisions are particularly
important in biological processes of today, where a high variance process may be feeding
a low-variance process and decisions must be made on what projects to work on with
limited development resources.
B. Theory
The sample coefficient of variation, defined as Cv is simply the ratio of the standard
deviation to the mean:
Cv =Sx / X, where C is the coefficient of variation, Sx is the sample standard deviation
and X is the sample mean.
The higher the coefficient of variation, the more difficult it is to discern incremental
improvements of the sample mean. The difficulty may be overcome by taking many
measurements of the effects of small changes on the process over time, also called
evolutionary operation (EVOP). Depending on the rate of generation of new
measurements, a modest process improvement may take a long time before it can be
confirmed as having had an effect. As discussed in the Variation Reduction chapter, the
Core Sequencing process had a relatively low coefficient of variation, less than 0.1
(Table 2). In contrast, Library Construction had a relatively high coefficient of variation,
0.5-1 (Table 3). Clearly, it is easier to discern small differences in performance in Core
Sequencing than in Library Construction.
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C. Results
The Center applied many incremental improvement methods to Core Sequencing,
resulting in high improvements in performance. When similar incremental improvement
methods were applied to Library Construction, there was a temporary increase in
performance initially, followed by a return to previous levels. Although there may have
been extenuating circumstances, the application of incremental tools did not correlate
well with increased performance. The reason for this is because it is very difficult to do
incremental improvements in the face of such high variability. Although some of the
variability was decreased, it was still not low enough to quickly find process
improvement paths. Additionally, there were special circumstances in Library
Construction, such as all tasks being performed manually with some degree of lab skill
required and high personnel turnover. In contrast, Core Sequencing was more fully
automated for the process critical tasks and had the full attention of the development
group.
During the internship, operations director decided to undergo a parallel improvement
path, where the development group was asked to work on an independent, radical
improvement effort designed to replace the existing Library Construction technology.
There were many changes in Library Construction; one of the large ones was in the
shearing operation, which was switched from an ultrasonic shearing to a "point sink" or
"hydroshearing" technique. According to authors of this new technique,15 the coefficient
of variation is less than 0.1. By the end of the internship, the technique was successfully
scaled up and implemented in Library Construction, resulting in a radical improvement in
their ability to supply the Core Sequencing step.
D. Conclusions
The ability to quickly ascertain the viability of incremental improvement efforts is an
utmost priority in the manufacturing sector and a simple statistic such as the coefficient
"5 "An Automated Hydrodynamic Process for Controlled, Unbiased DNA Shearing", Genome Research, Y.
Thorstenson et al, Vol. 8, Issue 8, pp. 848-855, August 1998.
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of variation can be used to help in decision-making. Although we have not addressed the
"middle ranges" of the coefficient of variation, it is clear that if a process is at either end
of the spectrum, the decision should be relatively straightforward.
The next question addresses the situation when there is no scale-up data available for
radical improvement. At this point, technical judgement should be used to decide
whether to try the incremental process using more appropriate techniques such as EVOP
or design of experiments (DOE) and/or generate scale-up data for radical improvement
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V. Conclusions
As the process for DNA sequencing matures, the people who run these processes must
decide whether to improve their processes by incremental improvement (staying on the S-
curve) or by radical improvement (moving to the next generation S-curve). The tradeoff
is the balance between taking advantage of the learning curve associated with continuous
improvement versus the disruptive effects of a large step change improvement. The
decision process is made even more difficult when the challenge is to increase output by
factors of three or more per year. To add another layer of complication, biological
processes are notoriously high in variation, making it even harder to decide which way to
go. The Center for Genome Research has done a remarkable job of balancing the
tradeoffs associated with these decisions, as witnessed by their recent increase in output
and subsequent extension of funding by the NIH.
A. The Use of Manufacturing Management Tools
Although the use of manufacturing management tools provide insights and can be very
valuable in the decision making process, they must be directly applicable to the problem
and be part of an overall operational strategy. In order to make the use of manufacturing
tools more relevant, they must be customized and evaluated for usefulness, requiring a
combination of technical expertise, experience and judgement. A high efficiency
organization must build their own tools to order to best evaluate and recommend
alternatives.
Manufacturing tools by themselves yield some marginal results, but work best when they
are part of the overall operational strategy and are applied where synergies can occur. An
example of this is cross-training: By cross training, the degree of variability eventually
decreases due to knowledge transfer, the ability to more easily respond to down-time
lowers the need for inventory. These effects lead to increased productivity and employee
engagement, eventually increasing the demand for cross-training. Good operational
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strategy requires a self-reinforcing, self-perpetuating system (virtuous cycle as defined by
Peter M. Senge16) where the needs of the organization and the people running the
organization are met.
Focusing a research organization on process improvements means changing a
fundamental part of their culture. As discussed by Schein, 7 cultures are very stable and
changing culture in any organizations is very difficult, requiring strong sustained
leadership and commitment at all levels. During the internship, the Center showed
leadership at the management level, but not necessarily at the worker level. It seems like
there is some resistance at the lower levels, mostly due to their perceived lack of
participation in improving the process.
B. Final Recommendations
Some additional virtuous cycles that the Center may be able to take advantage of include:
e Monitor variation and reduce it - although the Center prides itself in having much
sequencing data available on-line, it would be to their advantage to find some
variation statistics they can monitor to help them in finding ways of reducing
variability in the process.
* Improve the information exchange. At the factory-floor level, there is a lack of
metrics associated with targets. Without the right metrics and association with the
targets, it is difficult for employees to help improve the process. Although the overall
Center goals are clear, there is too much of a lag between what is done at the factory
floor and its effect on the process. The high variability of the processes emphasizes
the need for tools such as control charts to help differentiate a change in the process
from its normal variability.
16 "The Fifth Discipline: The Art and Practice of the Learning Organization", Peter M. Senge,
Doubleday/Currency, 1990
" "Organization Culture and Leadership", Edgar H. Schein, p.298, Jossey-Bass, 1992
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e Carefully consider use of QA - continuously monitor or eliminate the need for QA,
invest in making the process more robust rather than relying on testing.
* Manage inventory more carefully - as mentioned throughout the thesis, use low
inventory levels to help uncover erratic processes but mostly to reduce new
development ramp-up time.
* Increase employee involvement - enable the factory floor people to participate in
continuous improvement, assign a small workforce to do troubleshooting exclusively
for them or train some of them to do the routine maintenance replacement.
* Much of the incremental improvement shown in this process can be attributed to
following the principles of cGMP such as change control, detailed records, validation
of effects of changes on process and clear procedures. Although it may seem onerous
and costly to have a research organization follow cGMP/cGLP, the discipline
imposed may help the organization take better advantage of the learning curve.
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Exhibit 1: Whitehead Institute Operational Summary - Core Sequencing Operations (June, 1998)
Scenario: plates/day
ABI machines
plates/project
Throughput:
Average Project Size:
Plates/day:
Days/week:
Weeks/year:
Projects/year:
Average Project Size:
On-line Factor:
Bases/year:
29 plates
76.0
5
52
681
100,000 base pairs
90%
61.3 MB
Project Plate Breakdown:
SS's=
DS's=
QC/Lib=
Finishing=
Endmkrs=
Total=
12
12
2
2
1
29
plates
plates
plates
plates
plates
plates/project
Shotaun coverage Dattern:
SS
8
0
4
0
12
DS
6
6
0
0
12
Totals
14
6
4
0
24
SG plates
58.3%
25.0%
16.7%
0.0%
No. ABI's lanes/gel plates/gel ABI cycle
(hrs)
31.4 96.0 1.00 12
2.6 96.0 1.00 12
2.6 96.0 1.00 12
1.3 96.0 1.00 12
2.0 96.0 1.00 12
40.0 1.00
This part of the spreadsheet is used to
establish the throughput assuming the ABI
Sequencing machines are the bottleneck. The
shaded areas are variables that can be changed
to study effects.
Project
gels/day plates/day Proj. Alloc
62.9
5.2
5.2
2.6
4.0
62.9
5.2
5.2
2.6
82.8%
6.9%
6.9%
3.4%
80 76.0 100.0%
76.0
40
29
Proj Alloc
41.4%
41.4%
6.9%
6.9%
3.4%
100.0%
FP
RP
FT
RT
Totals:
ABI Machines:
Shotgun
QC/Library
Finishing
End,mkrs
Dev/Down
Total ABI's
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Exhibit I (continued): Whitehead Institute Operational Summary - Core Sequencing Operations (June, 1998)
Automation Factors:
Purpose:
Machine:
No. machines
No. of steps/machine
Machine cycle time
Max plates/machine
Batch size (plates)
Set-up time/batch
Process time/batch
Cycle time/batch
Labor time/plate
Residence time/plate
"Baby sit" factor
SS Picking
Flexys
1
4
10.0
8
8.0
10
110.0
120.0
1.3
120.0
0%
Purpose: FP TC
Machine: Tetrads
No. machines 5
No. of steps/machine 1
Machine cycle time 60
Max plates/machine 4
Batch size (plates) 19.0
Set-up time/batch 5
Process time/batch 60.00
Cycle time/batch 65.00
Labor time/plate 0.3
Residence time/plate 65.00
"Baby sit" factor 0%
SS/DS FT
Cascade
1
2
2
8
8.0
5
18.00
23.00
1.1
23.00
20%
SS/DS RP
Sequatron
I
5
2.5
20
16.0
5
50.00
55.00
1.1
55.00
25%
S Sup Xfer
Packard
1
1
0.6
8
8.0
2
4.67
6.67
0.4
6.67
25%
RP TC
Tetrads
5
1
60
4
16.0
5
60.00
65.00
0.3
65.00
0%
SS/DS RT
Cascade
1
2
2
8
0.0
5
4.00
9.00
#DIV/0!
9.00
20%
S Sup Xfer
Packard
1
1
0.6
8
8.0
2
4.67
6.67
0.4
6.67
25%
FT TC
Tetrads
5
1
150
4
2.0
5
150.00
155.00
2.5
155.00
0%
SS Purif
Tecans
1
10
6.7
15
15.0
10
160.0
170.0
6.0
170.0
50%
RT TC
Tetrads
5
1
150
4
0.0
5
150.00
155.00
#DIV/0!
155.00
0%
DS Purif
Hydras
1
15
6.0
40
16.0
10
180.0
190.0
6.3
190.0
50%
Pool P
P Tecan
4.5
1
1.0
0.5
4.50
5.00
0.5
5.00
0%
SS/DS FP
Sequatron
1
5
2.5
20
19.0
5
57.50
62.50
1.0
62.50
25%
Cascade T
Cascade
2
8
8.0
5
16.00
21.00
1.0
21.00
20%
A This part of the
spreadsheet is used
to enter data
regarding automation
and labor associated
with it. The shaded
areas are variables
that can be changed
to study effects.
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Exhibit 1 (continued): Whitehead Institute Operational Summary - Core Sequencing Operations (June, 1998)
Labor Factors:
Purpose: # Shifts
SS Picking
DS Picking
SS Sup Xfer
DS Sup Xfer
SS Sup QC
SS Purif
SS Purific QC
DS Purific
DS Purific QC
SS/DS FP
SS/DS RP
SS/DS FT
SS/DS RT
ABI load/prep
ABI plate prep
Coordinators
Total
Min # people req:
Req'd labor
per day
(hrs)
10.02
5.01
3.30
1.68
2.78
6.36
3.98
2.54
2.74
8.69
5.23
5.28
0.00
27.12
25.38
16.00
126.12
15.76
Assigned labor
% Total
8%
4%
3%
1%
2%
5%
3%
2%
2%
7%
4%
4%
0%
22%
20%
13%
per day
(hrs)
11
6
4
2
3
7
4
3
3
9
6
6
0
28
26
16
100% 134
Processing Factors:
Step
Pick/Xfer
Purification
Sequencing
Gel running
Total
Residence
Time
(hrs)
19.3
4.1
2.8
13.1
39.30
Inventory
Time
(hrs)
72
72
72
0
216.00
% time
in process
(hrs)
21.2%
5.4%
3.7%
100.0%
18.2%
People Plates Batches Batch Max Batch
assigned per day per shift size size
% Usage
91%
84%
83%
84%
93%
91%
100%
85%
91%
97%
87%
88%
n/a
97%
98%
100%
94%
1.38
0.75
0.50
0.25
0.38
0.88
0.50
0.38
0.38
1.13
0.75
0.75
0.00
3.50
3.25
2.00
16.75
31.4
15.7
31.4
15.7
31.4
31.4
31.4
15.7
15.7
36.7
15.7
10.5
0.0
76.0
76.0
3.93
1.97
3.93
1.97
1.05
2.10
2.10
0.98
0.98
1.93
0.98
1.31
0.00
4.00
4.00
(plates)
8.0
8.0
8.0
8.0
30.0
15.0
15.0
16.0
16.0
19.0
16.0
8.0
0.0
9.5
9.5
Labor Break-Out
Task Labor
QC (all)
Picking (all)
Sup Xfer (all)
SS Pur
DS Pur
Primer Seq
Term Seq
Coordination
ABI load/prep
ABI gel
Totals
9.50
15.04
4.98
6.36
2.54
13.92
5.28
8.00
27.12
25.38
118.12
(plates)
8
8
8
8
30
15
15
16
16
19
16
8
8
10
10
% Labor
8%
13%
4%
5%
2%
12%
4%
7%
23%
21%
100%
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This part of the
spreadsheet is used to
enter data regarding
shifts and calculates
number of batches per
shift needed. The
shaded areas are
variables that can be
changed to study
effects.
Exhibit I (continued): Whitehead Institute Operational Summary - Core Sequencing Operations (June, 1998)
Sup QC M13QC PUCQC
(wells/plate)
16
16
0
0
0
16
(wells/plate)
16
16
16
8
0
8
(wells/plate)
10
10
10
10
10
10
Capital
Cost/year
$ -
$ 8,000
$ -
$ -
$ -
$ -
Reagent
Cost/year
$ -
$ 47,697
$ -
$ -
$ -
$ -
QC labor
Cost/year
$ -
(55,556)
(18,057)
(31,003)
(43,949)
(12,946)
Prod. Loss
Cost/year
$ -
$ -
$ 7,849
$ 15,699
$ 23,548
$ 7,849
Net
Cost/year
$ -
$ 141
$(10,207)
$(15,304)
$(20,400)
$ (5,097)
Capital cost:
Depreciation period:
Overall plate "fail rate"=
Labor cost:
$/plate=
$ 16,000
2 years
3.0%
$ 25 per hour- based on base 11, fully loaded
$ 48 assumes no fixed head count
Other issues: Cytoflour reagent costs may be lower through dilution, may not give "extra" data that gel gives.
A This part of the spreadsheet is used to compare various
QC options for the supernatant transfer and purification
steps. The shaded areas are variables that can be
changed to study effects.
Plates/day
Sup Xfer 40.0
SS purifica 31.7
SS seq/AB 31.0
DS purifica 7.9
DS seq/AB 7.8
ABI gel 38.8
QC Options (sup, purif):
Scenario
Current
Cytofluor
0/16/10
0/8/10
0/0/10
16/8/10
Fail rate
1%
2%
0%
2%
0%
3.0%
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Exhibit 2: Whitehead Institute Process Flow Diagram - Core Sequencing Operations (June, 1998)
SS Picking (per Prep Prep
batch) area, deep
materi wells
Batch size (plates): 8.00 8.00
Set-up time/batch: 30 4
Process time/batch: 0 24.0
Cycle time/batch: 30.00 28.00
Labor time/plate: 3.75 3.50
Residence time/plate:
4 1 4 1
64.0 30 16.0 1.00
68.00 31.00 20.00 2.00
8.50 0.125 2.50 0.13
68.00 31.00 2.50 2.00
SS Sup Transfer (per
batch)
Batch size (plates):
Set-up time/batch:
Process time/batch:
Cycle time/batch:
Labor time/plate:
Residence time/plate:
SS Pur
batch)
Batch size (plates):
Set-up time/batch:
Process time/batch:
Cycle time/batch:
Labor time/plate: 2.33
Residence time/plate:
Prep
area,
mater
8.00 8.00 8.00 8.00
20 2.00 2.00 2.00
0 8.00 15.0 4.67
20.00 10.00 17.00 6.67
2.50 1.25 0.25 0.40
10.00 17.00 6.67
lo.uu Ilo.UU T:).vu lo.uu
5 1.00 1.00 10.00
30 30 15 160
35 31.00 16.00 170
2.07
31.00
1.07
16.00
6.00
170.0
Ck if Shake Wait
Ful Falco for full
Store ns batch
8.00 8.00 30.00
1 1 1.00
5 8.00 0.00
6 9.00 1.00
0.75 1.13 0.03
6 9.00 1.00
Ck if Sampi Load
OK Noe, add 1on I0
to dye agaro
15.00 15.00
5 1 1
5
10
0.67
10
20.0
21.0
1.40
25.0
26.0
1.73
21.0 26.0
A37
deg C
warm
8.00 PPD: 31.4 plates
5 PLPD: 10.0 proces
960 RT: 17.8 residei
965
0.63
965
>er day
; labor hours per day
ce time, hours
This part of the spreadsheet uses batch
sizes, set-up times, process times and
associated labor to calculate total labor
per step per day and theoretical process
residence time.
SS= single-stranded DNA (M13's)
The shaded areas are variables that can
be changed to study effects.
Sampi Load Run Take Doc
e, add on QC pictur DNA/
todye Iagaro es Prep
30.00 30.00 30.00 30.00 30.00
1 1 1 1 5
40.0 50.0 60 5 45
41.0 51.0 61 6 50
1.37 1.70 0.03 0.20 1.67
41.0 51.0 61 6 50
5
5
10
0.33
10
PPD:
PLPD:
QLPD:
RT:
31.4
3.3
2.8
1.5
plates
proc. I
QC lal
reside
>er day
bor hrs per day
:>r hrs per day
ce time, hours
Jr
Run Take Doc
QC picturl DNA/
es Prep
15.00 15.00
1 1 5
60
61
0.07
61
5
6
0.40
6
45
50
3.33
50
-20J To Sequencing Step
,gG C
ora
3. 0 PPD: 31.4 plates per day
5 PLPD: 6.4 process labor hours per day
5 QLPD
10 RT:
0.67
10
4.0
4.1
QC labor hours per day
residence time, hours
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Exhibit 2 (continued): Whitehead Institute Process Flow Diagram - Core Sequencing Operations
DS Picking (per Prep
batch) area, deep
materi wells
Batch size (plates): .% 8.00
Set-up time/batch: 30 4
Process time/batch: 0
Cycle time/batch: 30.00
Labor time/plate: 3.75
Residence time/plate:
DS
bat
24.0
28.0
3.5
Remo 4 deg
** ve ma " " C 1110
Stora
8.00
4 1
64.0 30
4
16.0
I
1.00
0 68.00 31.00 20.00 2.00
8.50 0.125 2.50 0.13
68.00 31.00 2.50 2.00
Sup Transfer (per Prep Balan Spin
ch) area, ce ... DWs ... 
materi -------- deep and
als wells Place
Batch size (plates): 8.00 8.00 8.00
Set-up time/batch: 20 2.00 2.00
Process time/batch: 0 8.00 15.0
gumu
O.Uu
2.00
4.67
Ck if Shake wait
" Full " " Falco" for full
Store ns batch
8.00 8.00 8.00
1 1 1.00
5 8.00 0.00
Cycle time/batch: 20.00 10.00 17.00 6.67 6 9.00 1.00
Labor time/plate: 2.50 1.25 0.25 0.40 0.75 1.13 0.13
Residence time/plate: 10.00 17.00 6.67 6 9.00 1.00
Sa m. . ..e. .
S Purification 
.e ..e .La
batch) areas)DNA
Batch size (plates): 16.0 '16.0'
Set-up time/batch: 5
Process time/batch: 30
Cycle time/batch: 35
Labor time/plate: 2.19
Residence time/plate: 35
5
5
10
0.63
10
Samp Load Run
16.0 1 .0 16.010
10
180
190
6.25
190
5
5
10
0.63
10
1
13.3
14.33
0.90
14.33
1
16.7
17.67
1.10
17.67
5
60
65
4.06
65
AIdegCf.......37
warm1
PPD: 15.7 platesper day
5 PLPD: 5.0 proce* labor hours per day
960 RT: 17.8 reside ce time, hours
965
0.63
965
W
.....................................m
PPD:
PLPD:
RT:
15.7
1.7
0.8
plates per day
process labor hrs per day
residence time, hours
5
5
Take _Doc
pictur DNA/I
16.0 16
5
5
10
0.63
10
5
45
50
3.13
50
10
1.25
10
ME~ W O EN MNoa 0E EN Mow s
To quencing Step
PPD: 15.7 plates per day
5 PLPD:
5 QLPD
10 RT:
0.63
10
2.5
2.7
4.3
process labor hours per day
QC labor hours per day
residence time, hours
This part of the spreadsheet uses batch
sizes, set-up times, process times and
associated labor to calculate total labor per
step per day and theoretical process
residence time.
DS= double-stranded DNA (pUC's)
The shaded areas are variables that can be
changed to study effects.
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Exhibit 2 (continued): Whitehead Institute Process Flow Diagram - Core Sequencing Operations
From IDS Purification Step
........................... S...
From SS Purification Step
Forward Pimers Prep Load Set
bac ........ area, . purif .. n. platesbatcl' plate
jatch ize (plates): 19 19 19 19
tet-u time/batch: 5 5 5 5
Ploces time/batch: 30 5 57.5 5
:Cycl time/batch: 35 10 62.5 10
Lab r time/plate: 1.84 0.53 1.02 0.53
Reiden time/plate: 0 10 62.5 10
ch i
tet-u time/batch: 5 5 5 5
P oces time/batch: 30 5 50 5
"Cyci. .time/batch: 35 10 55 10
bet-u time/batch: 5 5 5 5
FPoces time/batch: 30 5 50 5
:Cycl time/batch: 35 10 55 10
Lab. r time/plate: 2.19 0.63 1.094 0.63
Redident B time/plate: 35 10 55 10
ForwArd T Prep iii 0Load j Se
batc$j ara "* pui a* ** aM plates
datch ize (plates): 8 8 8 2
bet-u time/batch: 5 5 5 5
Foces time/batch:30515
Cycl time/batch: 35 10 23 10
:Lab r time/plate: 4.38 1.25 1.075 5.00
Residen time/plate: 35 10 23 10
rReerm TwI2Io rp La
batcI2~..... .. a0 N aea purifj*
Batch size (plates)
Set-up time/batch: 5 5
Process time/batch: 30
Cycle time/batch: 35
Labor time/plate: #####
Residence time/plate: 35
5
10
10
5
4
9
9
5
5
10
10
..
5.00
60.00
65.00
0.31
65.00
an 0
5
150
155
2.5
155
5.00
60.00
65.00
0.26
65.00
0.00
4.50
85.50
4.50
4.50
Trans
.. er to..
19
5
5
10
0.53
10
5
5
10
0.63
10
2
5
5
10
5.00
10
5
5
10
10
io
0.00
4.50
72.00
4.50
4.50
5.00
16.00
21.00
1.03
21.00
1-b
5
150
155
155
5.00
16.00
21.00
1.03
21.00
-00.
I IN 1111111.
-11110.
11111011111.
EAdd - SealEtOH , , plates
1.0 1.0
0.00 0.00
0.50 0.50
0.50 0.50
0.00 0.00
0.50 0.50
Add Seal
tOH plates
1.00
0.00 0.00
0.50 0.50
0.50
0.00
0.50
0.50
0.00
0.50
0
5
5
5.00
5
5
5
10
10.00
10
Add Seal
EtOH plates
1.00 1.00
0.00 0.00
0.50 0.50
0.50
0.00
0.50
5
5
10
10.00
10
0.50
0.00
0.50
To ABI e uencing Machines
PPD: 36.7 plates per day
PLPD: 8.7 process labor hours per day
RT: 2.8 residence time, hours
To ABI equencing Machines
PPD: 15.7 plates per day
PLPD: 5.2 process labor hours per day
RT: 3.3 residence time, hours
To 1equencing Machines
PPD: 10.5 plates per day
PLPD: 5.3 process labor hours per day
RT: 4.6 residence time, hours
S plates .. Stora equencing Machines
1.00 1.00 PPD: 0.0 plates per day
5 PLPD: 0.0
5 RT: 0.0
10
10.00
10
process labor hours per day
residence time, hours
This part of the
spreadsheet uses
batch sizes, set-up
times, process times
and associated labor
to calculate total labor
per step per day and
theoretical process
residence time.
Only 3 of 4 ways of
sequencing DNA are
actually used.
The shaded areas are
variables that can be
changed to study
effects.
0.00
0.50
0.50
0.00
0.50
0.00
0.50
0.50
0.00
0.50
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Exhibit 2 (continued): Whitehead Institute Process Flow Diagram - Core Sequencing Operations
jBI run (per bat Prep Balan Spin Aspira Evapo Add Shake
-area, .. ce .. Plates .. te ... rate ... Load ....
materi Plates EtOH Dye
Batch size (plates): . 9.50 9.50 9.50 9.50 9.50 9.50
Set-up time/batch: 5 5.00 5.00 6.00 5.00 5.00 5.00
Process time/batch: 30 9.50 30.0 9.50 30.0 9.50 9.50
Cycle time/batch: 35 14.50 35.00 14.50 35.00 14.50 14.50
Labor time/plate: 3.68 1.53 0.53 1.53 0.53 1.53 1.53
Residence time/plate: 0 14.50 35.00 14.50 35.00 14.50 14.50
ABI Prep (per batch) Scrap Rinse Dry Clean Asse
leGeli b Water Plates with ml P
Clean IPA Plates
Batch size (g-plates): 9.50 9.50 9.50 9.50 9.50 9.50 9.50
Set-up time/batch: 5 10 5 5 5 5 5
Process time/batch: 19 30 9.5 30 19 19 2.375
Cycle time/batch: 24 40 14.5 35 24 24 7.375
Labor time/g-plate: 2.53 1.05 1.53 0.53 2.53 2.53 0.78
................................. From Sequencing Step
From Sequencing Step
Spin Str eau Load .n Rem Data.... ..
to .. until .. re .. ABI ... 1.. ve Ge .. o Sor
repool ABI plates Plates g
9.50 .9.50 9.50 9.50 9.50
5.00 5.00 1.00 1.00 2.00 1.00
3.00 0.00 5.00 30.0 600 2.00
8.00 5.00 6.00 31.00 602.0 3.00
0.53 0.53 0.63 0.47 0.21 0.32
8.00 5.00 6.00 31.00 602.0 3.00
Add Set Store Rinse Place Place Run mw
Gel gel until ~'G- ~ on GP in ~InitialI Setup out
and un lat ~Cec~ Buffers wells
9.50 9.50 9.50 9.50 9.50 9.50 9.50 9.50 9.50
5 5 5 5 5 5 1 1
66.5 90 60 9.5 9.5 9.5 9.5 9.5 9.5
71.5 95 65 14.5 14.5 14.5 10.5 10.5 10.5
7.53 0.5 0.5 1.53 1.53 1.53 1.11 1.11 1.11
PPD: 76.0 plates per day
This part of the spreadsheet uses batch ALPD: 27.1 ABI run labor hours per day
sizes, set-up times, process times and PLPD: 25.4 ABI prep labor hours per day
associated labor to calculate total labor per RT: 13.1 residence time, hours
step per day and theoretical process
residence time.
ABI run is the sample prep and loading of
machines. ABI prep involves preparing the
machines to run
The shaded areas are variables that can be
changed to study effects.
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Exhibit 3: Whitehead Institute Scheduling Summary - Core Sequencing Operations (June, 1998)
63 SG plates/day
Shotgun: Picking Operations
4 8
Time from first shift, hours
Shotgun: Sequencing Operations
124 8
Time from first shift, hours
40 ABI machines
12
29 plates/project
Shotgun: Sup Transfer Operations
SS Sup QC 1
DS Sup 2
DS Sup I
SS Sup 4
SS Sup 3
SS Sup 2
SS Sup I
0
AI!
4 8
Time from first shift, hours
Scenario:
DS Pick 2
DS Pick I
SS Pick 4
SS Pick 3
SS Pick 2
SS Pick 1
0
FT Seq I
RP Seq I
FP Seq 2
FP Seq I
12
0
This part of the
spreadsheet plots out a
schedule based on the
data from the following
page.
As can be seen, the
three steps can be
accomplished in one
shift (8 hours).
69
Exhibit 3 (continued): Whitehead Institute Scheduling Summary - Core Sequencing Operations (June, 1998)
Picking
SS batches/shift:
DS batches/shift:
SS Pick I
SS Pick 2
SS Pick 3
SS Pick 4
DS Pick I
DS Pick 2
3.931 Batch size=
1.966 Batch size=
Initial Setup
0.50
2.95
5.40
5.40
0.50
2.95
Supernatant Transfer
SS batches/ 3.931
DS batches/ 1.966
QC batches 1.05
8.00 plates
8.00 plates
Pick
2.45
2.45
2.45
2.45
2.45
2.45
SS Sup I
SS Sup 2
SS Sup 3
SS Sup 4
DS Sup 1
DS Sup 2
SS Sup QC
0
1.16
1.99
2.82
3.64
4.46
5.27
Batch size=
Batch size=
Batch size:
Initial Setup
0.33
8.00 plates
8.00 plates
30 plates
Sup Xfer
0.83
0.83
0.83
0.83
0.81
0.81
Primer Sequencing Setups
F prim batches/day: 1.93 Batch size=
R prim batches/day 0.98 Batch size=
F term batches/day 1.31 Batch size=
Initial Setup
FP Seq 1 0 0.58
FP Seq 2 2.19
RP Seq 1 3.80
FT Seq 1 3.80
19
16
8
Add Seq
1.21
1.21
1.08
0.55
plates
plates
plates=
Thermal
1.25
1.25
1.25
2.75
AL
2 TC plates
Pool/Seal
1.61
1.61
1.38
0.53
QC
3.48
This part of the
spreadsheet calculates
a schedule based on
data from the process
flow diagram.
This data is used to
generate the plots on
the previous page.
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Exhibit 3 (continued): Whitehead Institute Scheduling Summary - Core Sequencing Operations (June, 1998)
Shotgun: Purification Operations
DS QC 1
DS Pur I
SS QC 2
SS Pur 2
M Initial Setup
SS QC 1 0 Purify
OQC
SS Pur 1
0
ABI Batch 4-8
Batches 4-8
ABI Batch 1-4
Batches 1-4
4 8 12
Time from first shift, hours
Shotgun: ABI Run Operations
0 4 8 12 16
Time from first shift, hours
20 24
This part of the
spreadsheet plots out a
schedule based on the
data from the following
page.
Purification can be
accomplished in 8 hous,
while the ABI
sequencing machines
run 24 hours per day.
71
Exhibit 3 (continued): Whitehead Institute Scheduling Summary - Core Sequencing Operations (June, 1998)
2.097 Batch size=
0.983 Batch size=
Initial Setup
0 0.58
Purification
SS batches/s
DS batches/
SS Pur 1
SS QC 1
SS Pur 2
SS QC 2
DS Pur I
DS QC I
A
QC
2.73
2.73
2.62
4.0 Batch size= 9.50
Load ABI's Wash Plates
0 1.87 2.69
1.87 10.13
9.25 0.00 0.00
13.87 10.13
plates
Pour Gels
1.19
0.00
Prep
2.27
2.27
Track
0.48
0.48
Load ABI's Wash Plates
1.87 2.69
4.37
4.37
8.15
0.58
4.67
15.00 plates
16.00 plates
Purify
3.78
3.78
3.500.58
This part of the
spreadsheet calculates
a schedule based on
data from the process
flow diagram.
This data is used to
generate the plots on
the previous page.
ABI Run
Batches/shif
Batches 1-4
ABI Batch I
Batches 4-8
ABI Batch 4
Pour Gels
1.19
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Exhibit 4: Whitehead Institute Statistical Measurements- Core Sequencing Operations
This is an example of the project tracking sheet used to coordinate operations.
Comments
Size of
project,
kilobases
LC entry
date
HO Entry
DateProject
L252
L258
L285
L221
L279
L223
L292
LI 23
L261
111
LI 13
L2941
L295
L296
L287
L290
L250
L259
L206
L257
L300
L302
L306
L309
LI 95
i T_
Size
200.00
105.00
95.00
145.00
50.00
180.00
130.00
105.00
125.00
130.00
140.00]
190.00
135.00
130.00
130.00
135.00
170.00
140.00
125.00
97.00
110.00
97.00
125.00
120.00
40.00
Status
GB
GB
SG
Fin
GB
GB
Assbly
Fin
Kil
Kill
Fin
GB
GB
GB
GB
GB
GB
Dead
GB
GB
GB
Fin
Fin
Kill
ABI
Roel
Roel
I I - - I - - I i
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Prep M13 Seq
Pick Date Date Date
10/21/97
11/05/97
11/08/97
11/10/97
11/11/97
11/14/97
11/14/97
1/5/97
11/16/97
11/19/9 rep is another word
11/19/9 for the Purification
11/24/9 tep
11/25/97
12/02/97
12/05/97
12/06/97
12/09/97 12/23/97 12/30/97
12/16/97 12/30/97 1/6/98
12/29/97 12/31/97 1/11/98
12/29/97 12/29/97 12/30/97
12/30/97 1/12/98 1/14/98
01/02/98 1/6/98 1/14/98
01/06/98 1/8/98 1/15/98
01/08/98 1/12/98 1/19/98_
01/08/98 1/15/98 1/19/98
M13
69/69
28/28
27/27
40/40
44/44
44/44
35/35
54/54
33/33
46/46
26/26
54/54
41/41
40/40
39/39
42/42
46/46,
34/34
31/31,
23/23
27/27
23/23
31/31
29/29
12/12
RR
25/25
13/13
4/4
6/6
3/3
n/a
4/4
n/a
5/5
7/7
8/8
n/a
n/a
6/6
4/4
5/5
7/7
7/7
6/6
6/6
6/6
7/7
7/7
2/2
pUCs
0/8
0/0
0/0
0/0
0/6
0/0
0/0
0/0
0/0
0/0
0/0
0/0
0/0
0/0-
0/0
0/0
0/0
0/0
0/0
0/0
0/0
0/0
0/0
0/0
0/0
KEY:
GB= Project finished, sent to
GENBANK
SG= Project in Shotgun (Core
Sequencing)
Fin= Project in Finishing Step
KiII= Project cancelled
L:QC= Project in Sequencing QC
L:LC=Project in Library Construction
HO= Project in Hand-Off (before Lib
Const)
ABI Date
01/06/98
12/22/97
12/16/97
12/30/97
01/07/98
12/23/97
12/11/97
12/15/97
12/13/97
12/24/97
12/28/97
12/12/97
12/19/97
12/30/97
12/23/97
01/06/98
01/09/98
01/15/98
01/19/98
01/13/98
01/21/98
01/22/98
02/25/98
02/25/98
01/28/98
Exhibit 4 (cont'd): Whitehead Institute Statistical Measurements- Core
Sequencing Operations, project data after assembly step Gap Data
Libr Initial Initial
Date of Overall Seq Pass Pass Avg. Avg. Read Length in % in Assembly:Ale Assembly:
Project Assembly Pass Rate Rate Rate Quality: Length Gap Gap wife Phrap
L252 2/11/98 65 72 97 791 512 513 61 17
L258 12/28/97 67 77 90 81 5231 539 57 10
L285 12/29/97 77 81 96 82 5341 542 71 9 The Center
L221 69 82 87 82 501 eventually
went to a
L279 2/11/98 78 84 94 84 550 533 64 14 new
L223 12/2297 71 81 90 831 541 555 41 16 software for
L292 12/22/97 83 89 95 87 560 562 75 11 dataI --- --- -I assembly
L123 65 75 91 79 499 436 25 13 called
L261 12/22/97 73 83 89 83 529 536 72 12 "Phrap".
-111 8/20/96 51 64 87 70 489 472 28
L113 9/96 53 59 94 66 456 371 28
L294 12/18/97 74 79 96 82 533 534 75 12
L295 12/25/97 85 89 96 87 562 563 77 5
L296 12/31/97 86 88 98 86 555 569 84 1
L287 12/26/97 86 89 97 86 527 546 86 9
L290 01/09/98 80 82 93 84 560 559 69 7
L250 01/15/98 76 83 93 83 554 531 77 10
L259 03/10/98 79 82 97 84 576 547 75 13
L206 03/10/98 67 76 92 801 534 419 7 28
L257 01/21/98 79 82 97 83 560 549 77 4
L300 01/29/98 76 82 94 83 546 534 74 4
L302 02/15/98 77 83 94 83 552 532 77 4
L306 03/15/98 76 81 95 83 577 544 70 11
L309 03/13/98 76 81 95 83 574 545 73 8
L195 03/05/98 82 88 93 85 554 524 71 9
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Exhibit 4: Whitehead Institute Statistical Measureme
This is an example of the project tracking sheet used
HO Entry LC entry
Project Size Status Comments Date date
L31 1
L228
L31 0
L291
L284
Two runs
L293
L288
L297
L283
L215
L286
L204
L299
L301
L313
L314
L315
L316
L317
L218
L312
L298_
L303
L318
L319
135.00
130.00
105.00
137.00
130.00
110.00
140.00
155.00
125.00
155.00
140.00
41.00
125.00
140.00
140.00
140.00
130.00
95.00
130.00
100.00
110.00
130.00
100.00
125.00
160.00
GB
GB
GB
Fin
Fin
Fin
Fin
GB
GB
GB
Fin
GB
Fin
Assbly
GB
GB
GB
GB
GB
Fin
Fin
Fin
Fin
Fin
Fin
eed 4 plates F/R by ETs
its- Core Sequencing Operations
to coordinate operations.
Prep
Pick Date Date
01/09/98 1/14/98
01/14/98 1/16/98
01/14/98 1/17/98
01/16/98 1/20/98
01/16/98 1/21/98
01/22/98 1/23/98
01/24/98 1/27/98
01/23/98 1/28/98
01/28/98 1/29/98
01/29/98 2/3/98
01/30/98 2/5/98
01/28/98 2/5/98
01/30/98 2/6/98
02/01/98 2/9/98
02/02/98 2/11/98
02/04/98 2/12/98
02/05/98 2/18/98
02/09/98 2/20/98
02/09/98 2/23/98
02/10/98 2/24/98
02/12/98 2/26/98
02/17/98 3/3/98
02/13/98 3/10/98
02/18/98 3/11/98
02/23/98 3/18/98
I
ABl
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M13 Seq
Date
1/20/98
1/22/98
1/25/98
1/29/98
1/30/98
2/2/98
2/3/98
2/5/98
2/3/98
2/11/98
2/16/98
2/17/98
2/19/98
2/23/98
2/25/98
3/2/98
3/5/98
3/9/98
3/10/98
3/11/98
3/12/98
3/19/98
3/22/98
3/23/98
3/25/98
M13
33/33
32/32
27/26
33/33
32/31
27/27
34/34
38/38
31/31
38/38
34/34
10/10
30/30
34/34
34/34
34/34
34/34
23/23
31/31
24/24
26/26
31/31
24/24
30/30
40/40
RR
8/8
7/7
6/6
8/8
6/6
4/4
6/6
10/10
4/4
6/6
6/6
2/2
4/4
6/6
6/6
6/6
6/6
4/4
6/6
4/4
4/4
6/6
4/4
4/4
6/6
pUCs
0/0
0/0
0/0
0/0
0/0
2/2
2/2
0/0
2/2
0/0
2/2
0/0
2/2
6/6
2/2
2/2
2/2
2/2
0/0
0/0
0/0
5/5
4/4
4/4
6/6
33/33
42/42
48/48
37/37
44/44
42/42
36/36
42/42
42/42
42/42
42/42
27/27
37/37
28/28
30/30
42/43
32/32
38/38
52/52
ABI Date
01/30/98
02/02/98
02/03/98
02/04/98
02/06/98
02/09/98
02/11/98
02/13/98
02/18/98
02/16/98
02/22/98
02/23/98
02/25/98
02/27/98
04/06/98
04/06/98
04/07/98
04/08/98
04/09/98
04/09/98
04/10/98
04/10/98
03/26/98
03/31/98
04/02/98
Exhibit 4 (cont'd): Whitehead Institute Statistical Measurements- Core
Sequencing Operations, project data after assembly step Gap Data
Libr Initial Initial
Date of Overall Seq Pass Pass Avg. Avg. Read Length in % in Assembly:Ale Assembly:
Project Assembly Pass Rate Rate Rate Quality Length Gap Gap wife Phrap
L311 02/10/98 74 84 90 841 602 589 70 6
L228 02/18/98 66 75 91 80 571 556 66 11
L310 02/15/98 75 79 96 81 569 553 73 4
L291 02/18/98 70 77 94 80 596 581 63 12
L284 02/19/98 71 79 92 82 613 578 69 5
Two runs
L293 02/24/98 77 84 92 84 649 615 66 6
L288 03/10/98 73 82 91 83 651, 625 77 12
L297 02/25/98 77 80 96 82 674 642 70 2
L283 02/25/98 66 71 95 79 660 613 65 4
L215 03/29/98 60 71 89 78 628 540 67 8
L286 04/04/98 66 72 93 79 660 619 70 5
L204 04/04/98 49 72 77 78 519 500 54 13
L299 05/04/98 76 82 94 83 684 654 78 15 4
L301 68 78 90 81 637 604 65 24
L313 04/17/98 74 79 95 82 676 639 66 4
L314 04/18/98 76 80 96 82 665 630 74 5
L315 04/16/98 78 83 95 84 691 650 70 3
L316 04/23/98 78 80 97 84 699 0
L317 04/18/98 78 80 97 83 702 655 73 6 10
L218 04/18/98 72 77 95 81 645 609 72 7 1
L312 04/16/98 72 77 96 81 686 644 65 4 3
L298 05/05/98 79 85 94 85 691 651 80 12 9
L303 05/25/98 67 73 94 77 611 13 5
L318 05/14/98 71 80 92 81 664 645 55 10 ?
L319 05/14/98 79 83 95 81 655 663 63 9 2
76
Exhibit 4: Whitehead Institute Statistical Measurements- Core Sequencing Operations
This is an example of the project tracking sheet used to coordinate operations.
HO Entry LC entry Prep M13 Seq
Projecti Size Status Comments Date date Pick Date Date Date M13 RR
New Coverage Rule: including vector 20 F 4R per 100 kb
L172 40.00 GB 02/24/98 3/23/98 3/25/98 8/8 2/
L308 120.00 Fin 02/25/98 3/24/98 3/29/98 25/25 4/,
L213 160.00 Fin 03/12/98 3/26/98 4/5/98 33/33 6/
L324 123.00 GB pUCs not in asmb stats 03/16/98 4/1/98 4/13/98 24/26 4/,
L289 125.00 Fin 03/19/98 3/27/98 4/15/98 26/28 0/
L321 100.00 Assbly 03/23/98 3/30/98 4/17/98 21/21 0/
L326 115.00 Fin pUCs not in asmb stats 03/26/98 4/7/98 4/21/98 24/24 0/
L327 103.00 Fin 03/27/98 4/8/98 4/21/98 19/20 0/
L322 120.00 Fin 03/30/98 4/9/98 4/16/98 25/25 0/
L330 105.00 Fin 04/07/98 4/21/98 5/3/98 22/21 0/
L334 158.00 SG ABI 6/15 04/09/98 4/22/98 4/30/98 32/32 0/
L333 135.00 Fin 04/10/98 4/29/98 5/1/98 28/30 0/
L323 85.00 SG2 ABI 6/12 04/13/98 4/30/98 5/4/98 20/17 0/
L329 95.00 SG{ ABI 6/12 04/15/98 5/5/98 5/11/98 25/20 0/(
change to 14Sa
L325 105.00
L332 115.00
L335 119.00
L337 137.00
L343 170.00
L255 140.00
L338
L339
L341
L340
L328
L346
180.00
200.00
160.00
190.00
80.00
190.00
SG2
SG
SG
Assbly
SG
SG
SG
SG
SG
SG_
SG
SG
ABI 6/12
05/01/98
04/08/98
04/08/98
04/08/98
04/08/98
04/21/98
05/03/98
04/21/98
04/21/98
04/21/98
05/03/98
05/05/98
05/07/98
05/06/98
05/07/98
05/08/98
5/7/98
5/8/98
5/11/98
5/10/98
5/10/98
5/13/98
05/12/98| 5/12/98| 5/13/98
05/19/98
05/19/98
05/21/98
05/21/98
05/26/98
05/28/98
05/29/98
06/01/98
25/24
25/25
27/27
4
4
0)
0)
O)
0)
0)
0)
O)
0)
0)
0)
0/0
0/0
0/0
29/291 0/0
pUCs
0/0
4/4
0/6
4/4
4/4
4/4
4/4
4/4
4/4
4/4
6/6
1/6
4/4
4/4
4/4
10/10
10/10
10/10
5/21/981 5/21/981 37/361 0/0 6/141
5/21/98
5/22/98-
5/26/98
5/29/98
6/1/98_
6/2/98
6/4/98
5/21/981 29/291 0/0
5/26/98
6/1/98
6/3/98
6/3/98
6/4/98
6/4/98
38/38
42/42
22/34
24/40
12/19
22/40
0/0
0/0
0/0
0/0
0/0
0/0
0/6
6/6
0/8
0/6
0/6
0/4'
0/8
ABI
10/10
33/33
39/45
32/34
30/32
25/25
28/28
23/24
29/29
26/25
38/38
34/36
24/21
29/24
29/28
24/29
26/31
29/35-
37/42
29/31
30/441
6/50
0/40
0/46
0/23
ABI Date
04/02/98
04/03/98
04/09/98
04/21/98
04/23/98
04/28/98
04/29/98
04/30/98
04/17/98
05/05/98
05/04/98
05/06/98
05/07/98
05/19/98
05/12/98
05/13/98
05/15/98
05/19/98
05/22/98
05/27/98
05/29/98
06/03/98
06/04/98
06/05/98
06/05/98
06/08/98
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Exhibit 4 (cont'd): Whitehead Institute Statistical Measurements- Core
Sequencing Operations, project data after assembly step
Project A
New Coverage
LI 72
L308
L213
L324
L289
L321
L326
L327
L322
L330
L334
L333
L323
L329
Date of
ssembly{
Rule: incl
04/17/981
05/08/98
05/01/98
05/19/98
05/15/98
06/12/98
05/20/98
05/28/98
05/27/98
06/07/98
06/08/98
06/01/98
change to DH5a
L325j
L332
L335
L337 06/12/98
L343
L255
L338
L339
L341
L340
L328
L346
Ove rall Seq Pass
Pass Rate
uding vector
77
69
72
74
70
66
72
69
74
77
69
76
72
75
78
78
89
89
89
88
88
96
Libr
Pass
Rate Rate
20 F 4R per 100
83 94
73 96
83 89
78 96
78 92
71 95
79 93
74 95
81 92
87 90
75 94
84 93
84 89
85 90
86
87
95
95
94
93
96
98
92
92
94
94
95
95
92-
98
Avg.
Quality
kb
84
79
84
801
79
76
75
63
75
71
71
72
66
66
59
54
51
51
43
48
45
67
Avg. Read
Length
687
658
699
659
662
637
639
699
715
710
724
714
716
765
722
779
805
801
798
740
784
783
Length in
Gap
632
555
665
652
660
% in
Gap
77
64
68
56
51
Gap Data
Initial
Assembly:Ale
wife
0
7
15
8
7
10
9
7
4
11
3
Initial
Assembly:
Phrap
5
3
3
1
I
2
4
1
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Exhibit 4: Whitehead Institute Statistical Measurements- Core Sequencing Operations
This is an example of the project tracking sheet used to coordinate operations.
HO Entry LC entry Prep M13 Seq
Project Size Status Comments Date date Pick Date Date Date M13 RR pUCs ABI ABI Date
New Coverage 12 M13 8Pr, 4T; 12 pUC, 6F:6R Pr per 100kb, incl vector
L347 175.00 SG 05/01/98 05/07/98 06/03/98 6/5/98 6/8/98 15/22 0/11 06/10/98
L345 165.00 SG 05/01/98 05/14/98 06/08/98 6/9/98 6/9/98 13/21 0/10
L336 190.00 SG 03/19/98 5/19/98 06/10/98 6/10/98 6/12/98 16/24 0/12
L348 180.00 SG 05/01/98 06/08/98 6/9/98 6/11/98 16/23 0/11
L350 200.00 SG 05/11/98 5/21/98 06/11/98 0/25 0/13
L351 185.00 SG 05/11/98 5/21/98 0/23 0/11
L352 170.00 SG 05/11/98 5/21/98 0/21 0/10
L354 165.00 L:QC pUCs only, McPrep!! 05/11/98 5/26/98 0/21 0/10
L356 180.00 L:QC electroporation 05/11/98 5/26/98 0/23 0/11
L342 200.00 LLC 04/09/98 6/8/98
L344 190.00 L:LC 05/14/98 6/8/98
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Exhibit 4 (cont'd): Whitehead Institute Statistical Measurements- Core
Sequencing Operations, project data after assembly step
Project
New Coverage
L347
L345
L336
L348
L350
L351
L352
L354
L356
L342
L344
Date of
Assembly
Overall Seq Pass
Pass Rate Rate
12 M13 8Pr, 4T; 12 pUC,
Libr
Pass
Rate
Avg. Avg. Read
Quality Length
6F:6R Pr per 100kb, incl vector
Length in
Gap
% in
Gap
Gap Data
Initial
Assembly:Ale
wife
Initial
Assembly:
Phrap
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Exhibit 5- Regression of B/W(Wc/Bc) vs. %SV y = 0.4779x + 0.0098R2 = 0.5853
5.0% 10.0% 15.0% 20.0% 25.0%
BIW(Wc/Bc)*100%
30%
25%
20%
I..
0
C,
0*
w
Co
15%
10%
5%
0% -
0.0% 30.0%
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y= 1.2013x - 0.0148
Exhibit 6- Regression of B/W(Wc/Bc) vs. %SV+SI R= 0.7861
40%
35% -
30%
25%
E
+20%
0
wor 15%
10%
5%
0%
0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0%
BIW(Wc/Bc)*100%
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Exhibit 7: Operating Characteristic Curves
1
0.98
0.96
0.94
0.92
0.9
0.88
0.86
0.84
0.82
0.8
*0
0)
0
0.)
-
.o
0D o --
of 16
samples defective
- Fail if > 1 out of 8 samples
defective
0 0.01 0.02 0.03 0.04 0.05 0.06 0.07 0.08 0.09 0.1 0.11
Proportion of defectives in the lot
83
-+-Fail if > 3 out
Relevant region is 1-2%
defectives, which is mean
value for the pruification
and supernatant transfer
steps
Defects greater than 10%
occur in less than 2% of
projects
Exhibit 8 Whitehead Institute - Library Construction Sequencing QC
Seq QC Cost Model
Mean project quality w/o QC:
Plates/proj:
New Library Cost:
Cost of Seq:
% Lost QC Data:
Total No. Max No.
Test Wells Well Fails % Lib Fails
96
96
96
96
96
96
96
96
96
96
96
96
96
96
96
96
96
96
96
96
96
Total No.
Test Wells
192
192
192
192
192
192
192
192
192
192
192
192
192
192
192
192
192
192
192
192
192
4.0
5.0
6.0
7.0
8.0
9.0
10.0
11.0
12.0
13.0
14.0
15.0
16.0
17.0
18.0
19.0
20.0
21.0
22.0
23.0
24.0
Max No.
Well Fails
8.0
10.0
12.0
14.0
16.0
18.0
20.0
22.0
24.0
26.0
28.0
30.0
32.0
34.0
36.0
38.0
40.0
42.0
44.0
46.0
48.0
4.2%
5.2%
6.3%
7.3%
8.3%
9.4%
10.4%
11.5%
12.5%
13.5%
14.6%
15.6%
16.7%
17.7%
18.8%
19.8%
20.8%
21.9%
22.9%
24.0%
25.0%
% Lib Fails
4.2%
5.2%
6.3%
7.3%
8.3%
9.4%
10.4%
11.5%
12.5%
13.5%
14.6%
15.6%
16.7%
17.7%
18.8%
19.8%
20.8%
21.9%
22.9%
24.0%
25.0%
Proj Qual
4.0%
5.1%
5.8%
6.5%
7.0%
7.9%
8.3%
8.8%
9.1%
9.3%
9.5%
9.5%
9.5%
9.5%
9.5%
9.5%
9.5%
9.5%
9.5%
9.5%
9.5%
Proj Qual
4.0%
5.1%
5.8%
6.5%
7.0%
7.9%
8.3%
8.8%
9.1%
9.3%
9.5%
9.5%
9.5%
9.5%
9.5%
9.5%
9.5%
9.5%
9.5%
9.5%
9.5%
Fraction
accepted
0.04
0.10
0.18
0.30
0.43
0.57
0.70
0.80
0.88
0.93
0.96
0.98
0.99
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
Fraction
accepted
0.00
0.02
0.07
0.18
0.34
0.54
0.72
0.85
0.93
0.97
0.99
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
Library costs/proj:
Quality
$ 270
$ 346
$ 389
$ 436
$ 475
$ 536
$ 562
$ 591
$ 612
$ 630
$ 641
$ 641
$ 641
$ 641
$ 641
$ 641
$ 641
$ 641
$ 641
$ 641
$ 641
Library costs/proj:
Quality
$ 270
$ 346
$ 389
$ 436
$ 475
$ 536
$ 562
$ 591
$ 612
$ 630
$ 641
$ 641
$ 641
$ 641
$ 641
$ 641
$ 641
$ 641
$ 641
$ 641
$ 641
$
$
9.5%
30
1,325
225
50%
per library
per plate
Generate
30,524
13,647
7,258
4,448
3,063
2,321
1,901
1,655
1,509
1,425
1,376
1,350
1,337
1,330
1,327
1,326
1,325
1,325
1,325
1,325
1,325
Generate
295,905
60,733
18,156
7,372
3,847
2,460
1,844
1,554
1,419
1,360
1,336
1,328
1,326
1,325
1,325
1,325
1,325
1,325
1,325
1,325
1,325
Lost Data
2,479
1,046
504
265
148
85
49
28
16
8
4
2
1
0
0
0
0
0
0
0
0
Lost Data
50,023
10,088
2,858
1,027
428
193
88
39
16
6
2
1
0
0
0
0
0
0
0
0
0
Total
Lib Costs
33,273
15,039
8,151
5,149
3,686
2,941
2,512
2,273
2,137
2,063
2,022
1,994
1,979
1,972
1,969
1,967
1,967
1,966
1,966
1,966
1,966
Total
Lib Costs
346,198
71,167
21,403
8,835
4,751
3,188
2,494
2,184
2,048
1,996
1,980
1,970
1,967
1,966
1,966
1,966
1,966
1,966
1,966
1,966
1,966
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Exhibit 8 (continued) Whitehead Institute -Library Construction Sequencing QC
3,600
3,400
3,200
3,000
2,800
2,600
2,400
2,200
2,000
1,800
8% 9% 10% 11% 12% 13% 14% 15% 16% 17%
Maximum acceptable Seq QC
18% 19% 20%
Library costslproj:
Quality Generate
270 2,554,481
346 242,947
389 41,374
436 11,334
475 4,584
536 2,538
562 1,787
591 1,490
612 1,376
630 1,338
641 1,328
641 1,325
641 1,325
641 1,325
641 1,325
641 1,325
641 1,325
641 1,325
641 1,325
641 1,325
641 1,325
C-)
U
Costs of Library Quality per Project
-+-1 QC plates/proj,
sample size 96
-U-2 QC plates/proj,
sample size 192
-a-3 QC plates/proj,
sample size 288
Total No.
Test Wells
288
288
288
288
288
288
288
288
288
288
288
288
288
288
288
288
288
288
288
288
288
Max No.
Well Fails
12
15
18
21
24
27
30
33
36
39
42
45
48
51
54
57
60
63
66
69
72
% Lib Fails
4.2%
5.2%
6.3%
7.3%
8.3%
9.4%
10.4%
11.5%
12.5%
13.5%
14.6%
15.6%
16.7%
17.7%
18.8%
19.8%
20.8%
21.9%
22.9%
24.0%
25.0%
Proj Qual
4.0%
5.1%
5.8%
6.5%
7.0%
7.9%
8.3%
8.8%
9.1%
9.3%
9.5%
9.5%
9.5%
9.5%
9.5%
9.5%
9.5%
9.5%
9.5%
9.5%
9.5%
Fraction
accepted
0.00
0.01
0.03
0.12
0.29
0.52
0.74
0.89
0.96
0.99
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
Lost Data
650,332
61,545
10,201
2,549
830
309
118
42
13
3
1
0
0
0
0
0
0
0
0
0
(0)
Total
Lib Costs
3,205,083
304,839
51,964
14,319
5,890
3,383
2,468
2,123
2,002
1,971
1,970
1,967
1,966
1,966
1,966
1,966
1,966
1,966
1,966
1,966
1,966
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Exhibit 9: Whitehead Institute- Core Sequencing Operations
Histogram of Picked Plates per Day
Sample Size = 110 days, Mean = 20
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Exhibit 10: Whitehead Institute- Core Sequencing Operations
Histogram of Purified Plates per Day
Sample Size = 110 days, Mean = 18
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Exhibit 11: Whitehead Institute- Core Sequencing Operations
Histogram of Sequenced Plates per Day
Sample Size = 110 days, Mean = 21
0.6
0.5
0.4
0.3
0
IL
.
0.2
0.1
0
0 1-4 5-9 10-
14
15- 20- 25- 30- 35- 40- 45- 50-
19 24 29 34 39 44 49 54
Plates Sequenced in One Day
88
Exhibit 12: Whitehead Institute- Core Sequencing Operations
Histogram of Plates Run on ABI per Day
Sample Size = 25 days, Mean = 28
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Exhibit 13: Whitehead Institute Stochastic Simulation of Inventories for Core Sequencing
80
120
Mean Throughput Rates: Throughput "Multipliers"
30 30 24 20
Date Sup InvPur
1 70
2 70
3 70
4 100
5 70
6 100
7 70
8 70
9 70
10 100
11 70
12 100
13 70
14 70
15 70
16 100
17 70
18 100
19 70
20 70
21 70
Inv
50
56
62
38
68
44
50
56
62
38
68
44
50
56
62
38
68
44
50
56
62
Seq Inv ABI Inv
100 0
104 20
108 40
112 60
92 80
96 100
100 120
104 140
108 160
112 180
92 200
96 220
100 240
104 260
108 280
112 300
92 320
96 340
100 360
104 380
108 L 400
Sup
30
30
30
0
30
0
30
30
30
0
30
0
30
30
30
0
30
0
30
30
30
Pur
30
30
0
30
0
30
30
30
0
30
0
30
30
30
0
30
0
30
30
30
0
Seq
24
24
24
0
24
24
24
24
24
0
24
24
24
24
24
0
24
24
24
24
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ABI Sup Pur Seq ABI
20
20
20
20
20
20
20
20
20
20
20
20
20
20
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